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Objective: To investigate, by systematically reviewing the literature, if the ADHD polygenic 
risk score (PRS) associates with ADHD and related traits in independent clinical and 
population samples. 
 
Method: Pubmed, Embase and PsychoInfo were systematically searched, alongside study 
bibliographies.  Quality assessments were conducted, and a best-evidence synthesis was 
applied. Studies were excluded when 1) predictor was not based on the latest ADHD genome-
wide association study; 2) PRS was not based on genome-wide results; 3) study was a review. 
Initially, 197 studies were retrieved [dd. Feb 22nd 2020]; a second search [dd June 3rd 2020] 
retrieved a further 49 studies; from both searches, 57 studies were eligible and 44 studies met 
inclusion criteria. 
 
Results: Included studies were published in the last three years. Over 80% of the studies were 
rated excellent based on a standardized quality assessment. Evidence of associations between 
ADHD PRS and the following categories was strong: ADHD, ADHD traits brain structure, 
education, externalizing behaviors, neuropsychological constructs, physical health and socio-
economic status.  Evidence for associations with addiction, autism and mental health are 
mixed and were, so far, inconclusive. Odds ratios for PRS associating with ADHD ranged 
from 1.22-1.76; variance explained in dimensional assessments of ADHD traits was 0.7%-
3.3%. 
 
Conclusion: A new wave of high quality research using the ADHD PRS has emerged. 
Eventually, symptoms may be partly identified based on PRS, but the current ADHD PRS is 
useful for research purposes only.  This review shows the ADHD PRS is robust and reliable, 
associating not just ADHD but many outcomes and challenges known to be linked to ADHD. 
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ADHD is a neurodevelopmental disorder that affects approximately 5% of children 
and 2.5% of adults1. Decades of past research have established the significant twin heritability 
of ADHD and family studies demonstrate its high familiality2,3. More recently, significant 
SNP heritability estimates for ADHD have been reported4. Together this evidence supports 
the hypothesis that common genetic variants acting additively play a role in the causes of 
ADHD3. In addition, twin, family, and molecular genetic studies suggest that these common 
variants may to some degree be shared with other conditions and traits, including autism and 
autistic traits5,6,7,8,9,10, tobacco and alcohol use11,12, and depressive and hypomanic 
symptoms13,14,15.  
A genome-wide association study (GWAS) is the principal tool for identifying 
common genetic variants across the genome that influence complex traits16. Following 
previous GWAS’s using comparatively smaller samples, the latest GWAS on individuals with 
ADHD (n=20,183) and controls (n=35,191) identified 12 independent loci associated with 
ADHD17.  Several characteristics of the study suggested that these findings were robust: for 
example, significant SNP heritability of 22% was reported, the genome-wide significant loci 
were replicated, and no marker demonstrated heterogeneity between studies.   
GWAS data can be used to create a polygenic score, or, as often referred to in studies 
of psychopathological traits, a polygenic risk score (PRS). PRS’s can estimate an individual’s 
genetic liability for a particular disorder or trait, based on current knowledge of the trait’s 
genetic architecture. Technically, a PRS is calculated as the weighted sum of the risk alleles, 
carried by an individual, which are associated with a disorder based on a GWAS. Demontis et 
al17 reported that the variance in ADHD explained by their ADHD PRS was 5.5% in 
individuals of European ancestry (note that European ancestry individuals were also used to 
calculate the score).  In their samples, the PRS had an OR of 1.56 between cases and controls 






































































ADHD. PRS’s can be calculated in any genotyped sample and thus the degree to which the 
ADHD PRS associates both with ADHD as well as other phenotypes can be explored.  The 
latter is interesting given the reported co-occurrence and genetic overlap of ADHD with many 
other traits like autism and substance use, as described above. 
A PRS is thus a major methodological development, not only for the genetic field, but 
in terms of potential utility in a range of other research fields due to the fact that they can be 
easily calculated in any genotyped sample.  The potential of PRS for clinical utility, screening 
and personalized health is currently a major topic of debate18,19.   
Here we present a systematic review of all studies using the ADHD PRS based on the 
largest ADHD GWAS to date17 and provide a systematic quality assessment of all included 
studies.  In our review, we structured our results by the following outcome domains: 
diagnosed ADHD and ADHD traits (dimensional assessments of ADHD symptoms or traits), 
addiction, autism and autistic traits, brain-based (imaging) measures, educational attainment, 
externalizing behaviors, , mental health, neuropsychological constructs, physical health, 
socioeconomic variables and other (uncategorized) outcomes. Please see Table S1 for the 
complete list of outcomes per category. We also note the ancestry of the samples used in the 









































































Details of the outline of our review and methods applied were preregistered with PROSPERO 
Framework (https://www.crd.york.ac.uk/PROSPERO) with registration number 
CRD42020176391 on April 28 2020, and followed as registered except the following: 1) The 
study by Hayden et al. (2013), on which we based our quality assessments, proposes six 
quality domains. However, given some overlap in items of domains 1 and 2, we combined 
these, and thus used five domains instead of six. 2) Given the sheer amount of studies 
resulting from the latest GWAS (n= 44), and the importance of an adequately powered 
GWAS to use the PRS reliably, we decided to exclude a systematic overview of studies based 
on older GWAS’s.   
 
Study selection 
PubMed, Embase, and PsychInfo were systematically searched for published, peer reviewed 
studies written in English using the search terms: (“ADHD”[Title/Abstract] OR “Attention 
Deficit”[Title/Abstract] OR “Attention-Deficit”[Title/Abstract] OR 
"Hyperactivity"[Title/Abstract] OR “Hyperactive”[Title/Abstract] OR "attention deficit 
hyperactivity disorder“[Title/Abstract] OR "Attention problems”[Title/Abstract]) AND 
(“Polygenic risk score”[Title/Abstract] OR “Polygenic score”[Title/Abstract]). Bibliographies 
of selected studies were also searched (by NB). A first search was conducted February 22nd 
2020, and a second search on June 3rd 2020. All abstracts were inspected by two reviewers 
(TJCP and NB). Studies were excluded when a) the predictor was not an ADHD PRS b) the 
PRS was not based on genome-wide results (but e.g., on a certain selection of SNPs) c) the 







































































Figure 1 provides a flowchart on the selection and reasons for exclusion of studies.  
 
INSERT FIGURE 1 
 
The ADHD PRS  
GWAS results allow the calculation of an individual polygenic risk score (PRS), which is 
based on the aggregate effect of common genetic variants that are associated with the trait of 
interest20,21. The PRS can be used to test the association between the aggregated common 
genetic risk for ADHD and other human traits.   
 
Categorization of outcome measures 
Categorization of outcomes was loosely based on ICD/ICF22,23 but not completely for the 
following reasons. First, these classification systems would have meant losing specificity. 
Second, these systems are not designed specifically with ADHD in mind. For example, we 
chose to categorize externalizing behaviors and addiction as two specific categories, due to 
their relevance to ADHD, rather than putting them under the umbrella category of mental 
health.  Thus, some categories were made more or less specific, based on deliberation and 
consensus between AR and TP.  Outcomes that were only studied once and did not fall 
readily into categories with other outcomes were placed in an ‘Other’ category. Table S1 




In general, scientific studies may encounter various biases resulting in potentially reduced 






































































series of quality assessment criteria, clustered in five domains, to evaluate the quality of 
studies that we included in the current review.  
 
1. Study participation  
A clear description of characteristics of the sample under study is key to evaluate how 
adequately the sample represents the population of interest, and how potential attrition may 
lead to selection bias affecting a proper representation. 
 
2. The ADHD PRS  
The validity and statistical power of a PRS depends on two crucial conditions. The first one is 
a powerful GWAS discovery sample, and the second one is proper quality control (QC) of the 
genetic data of the target sample under study. With the publication of the summary statistics 
of the largest GWAS on ADHD three years ago17, for the first time, a reasonably powerful 
ADHD PRS became possible.  Standard QC protocols are available26 to ensure that genetic 
data are correctly processed, and that important data checks are applied. Furthermore, when 
analysing PRS data, a proper correction for population stratification should be applied.  
 
3. Assessment of outcome measures 
The current review includes multiple outcome measures that were tested for an association 
with the ADHD PRS. In the quality assessment, the validity and reliability of these outcome 
measures, either tested in the study, or as citation to earlier publication, were the focus of 
evaluation.  
 






































































Several confounding factors can play a role in the relation between the genetic risk for ADHD 
and the outcome measures. Given the variety of outcome measures the focus of evaluation 
was on the following generic confounders: gender, age, socioeconomic status (SES), use of 
medication and co-occurring disorders. 
 
5. Analysis and data presentation 
For a reader to judge the quality of a study, a proper presentation of the statistical analyses 
and results is required. Of importance is also the target sample size, as sufficient statistical 
power is required to provide accurate conclusions on the relation between the ADHD PRS 
and outcome measures. Lastly, multiple testing correction should be applied when more than 
one outcome measure is tested for an association with the predictor variable (i.e., ADHD 
PRS).  
 
A checklist consisting of criteria as described above was used to evaluate the quality of the 44 
selected studies. Every item was rated positive (+), negative (-), or +/- (i.e., fulfilling part of 
the criterium) by two independent reviewers (TJCP and NB). In case of any disagreement 
between the reviewers, consensus was achieved by discussion. Studies were then ranked 
based on the number of biases. A bias was present when more than 50% of the criteria of one 
domain had a negative score. The highest quality was attained if at least 50% of the items of 
each domain were rated as being positive24,25. Of note, since item M (treatment and 
comorbidity) could only be rated for the clinical samples, and not applicable (NA) for the 









































































Within each of the categories, considerable variation was present in outcome measures. 
Therefore, we performed a best-evidence synthesis, to define the evidence for a true 
association between the ADHD PRS and respective outcome category. The evidence for each 
category was determined by taking into account the number of studies evaluating this 
association, the quality of these studies, and the consistency of findings across studies27. 




The 44 studies that met our inclusion criteria are listed in Table 1, and the results are 
summarized in Figure S1. Categories of outcome(s) are given in the first column for each 
study. Samples are described in terms of name (where available), type, nationality, size, sex 
and age ranges. Choice of SNP p-value threshold (pT) is listed in the 4th column; Outcomes 
along with covariates are listed in the 5th column. Results (6th column) focus on the statistics, 
effect sizes and their direction, for direct effects. The Results column describes any mediation 
analyses in terms of % reduction in direct effect and outlines any sensitivity/replication 
analyses. Negative findings are reported but statistics for negative findings are omitted for 
space considerations. The Results column also specifies the author(s)’ choice of significance 
threshold for testing the association between the ADHD PRS and outcome measure(s).  
 
INSERT TABLE 1 
 
Descriptives of outcome measures and samples 
Outcome measures were categorized in the following domains (number of studies 






































































substance-based addiction phenotypes (n=8), autism spectrum disorders or autistic traits 
(n=5), brain-based (imaging) variables (n=8), educational attainment (n=9), externalizing 
behaviors (n=8), mental health (n=11), neuropsychological constructs (n=6), physical health 
(n=4), socio-economic variables (n=4) and “other” (uncategorized outcomes) (n=9).  
Across the 44 studies, a total of 48 samples were used. Four studies included two 
samples and note that these 48 samples are not all independent (see below). In terms of 
sample characteristics, 25 of the 48 samples (52%) were population samples, 16 (33%) were 
clinical samples and 7 (15%) were community samples enriched for individuals with ADHD 
or mental illness. Children (under 18’s) made up just over half the samples (n=25; 52%), 13 
(27%) were adult samples and the remaining (n = 10, 21%) included both children and adults.  
It was most common for samples to come from Europe (n = 25, 52%) followed by North 
America (n = 17, 35%), a mix of continents (n= 4, 9%), Asia (n = 1, 2%) and one had missing 
country of origin (2%). The samples employed in more than one study were ALSPAC (6 
studies), IMAGEN (3 studies), National Longitudinal Study of Adolescent to Adult Health (3 
studies), Child and Adolescent Twin Study in Sweden (3 studies), Generation R (2 studies), 
community based sample recruited close to Oregon Health & Science University USA (2 
studies), and iPSYCH (2 studies).  
 Diagnosed ADHD. The ADHD PRS consistently associated with diagnosed ADHD in 
all 10 studies. The odds ratios ranged from 1.22-1.76. This range omits one study which 
associated with ADHD within a cohort with bipolar disorder29 and two studies which did not 
provide enough information to calculate odds ratios30,31.  Several studies17,32 showed, using 
deciles or groups based on low/medium/high scorers, that the ADHD PRS operated in a dose 
dependent manner in terms of its influence on ADHD status.   
In terms of ADHD and co-occurring conditions, ADHD PRS was associated with 






































































and relatives with either or both conditions31. The ADHD PRS did not differentiate bipolar 
disorder cases with ADHD from bipolar disorder cases without ADHD29.  In the context of 
other psychiatric disorders, ADHD PRS was associated with ADHD when controls were 
individuals with other psychiatric disorders33;  
ADHD Traits.  This was the most commonly studied outcome and all studies found 
positive significant associations with the ADHD PRS (16 studies). Percent variance explained 
in ADHD traits by the ADHD PRS ranged from 0.7-3.3%. These values were either directly 
reported, or converted from correlations provided in the studies. Five studies that reported on 
ADHD traits29,34,35,36,37 are omitted from this range because their study designs were different 
(e.g. they only investigated subscales, they investigated familial effects, the sample was 
bipolar disorder cases).   
Four of these studies investigated the ADHD trait subscales separately, namely 
hyperactivity/impulsivity and inattention. Two (50%) studies found that the ADHD PRS was 
positively associated with higher scores on both subscales38,39 whereas two (50%) found that 
the ADHD PRS was positively associated with the hyperactivity/impulsivity subscale but not 
significantly associated with inattention33,36. 
Addiction. A range of addiction phenotypes were studied: seven studies on substance 
related addiction32,40,33,41,42,43,44 and one study on a non-substance related addiction – 
gambling45.  Three studies did not find the ADHD PRS associated with their addiction 
phenotypes (which focused on gambling behaviors, substance abuse and marijuana use 
disorders).  The other five studies reported all or some significant positive associations, 
including with cocaine dependence, substance use disorders, alcohol (intake frequency and 







































































Autism spectrum disorders and autistic traits. Five studies investigated diagnosed 
autism or autistic traits. Only one (on autism) reported a significant positive association with 
the ADHD PRS, although full effect sizes were not provided31.  One study on autistic traits 
reported a significant positive association in males only but the effect was not present for the 
full sample or in females46.  
Brain-based (imaging) phenotypes. All but one of the eight studies on brain structure 
or connectivity47,48,49,50,51,36,52,37 reported significant associations with the ADHD PRS.  Five 
of these also conducted mediation analyses, within which there was a variety evidence that 
brain structure mediates the association between the ADHD PRS and ADHD. The specific 
brain-based outcomes are listed in Table S1: 7 of the 8 studies included structural 
measurements, including both gross indices such as grey matter volume or more detailed 
measurements such as subcortical structures; two studies included functional parameters.   
Educational attainment. Seven  of the nine studies reported that the ADHD PRS was 
associated with lower educational attainment32,33,35,36,44,53,54 . One nonsignificant finding came 
from a study which did not test a straightforward association but separated the PRS into 
transmitted and nontransmitted alleles34 and thus tested two separate PRS’s for their 
association with educational attainment, which reduces power.  
Externalizing behaviors. The ADHD PRS was significantly positively associated with 
a range of externalizing behaviors across eight studies: cross-sectional assessments of 
irritability, surgency, impulsivity, aggression, risk taking, and there was evidence that the 
ADHD PRS was also associated with trajectories of increasing and persistent irritability and 
with high decreasing trajectories of externalizing behaviors55,33,56,57,50,44,58. 
Mental health. Within this category, there were 11 studies21,32,54,59,29,60,61,35,44,62  with a 
broad range of phenotypes but not consistent significant findings. The ADHD PRS was 






































































referred to as ‘p’ factor)60. Higher ADHD PRS was associated with a bipolar disorder subtype 
combined with ADHD when compared to unaffected controls but did not associate with 
bipolar disorder when compared to unaffected controls.  Four studies explored schizophrenia 
or subthreshold psychotic experiences, and none reported a significant association with the 
ADHD PRS.  In terms of anxiety, depression and neuroticism, results were mixed. For 
example, the ADHD PRS was associated with higher neuroticism in one study of older 
adults44, and more perceived stress in another study32 but was not associated with neuroticism 
in a youth sample . The ADHD PRS positively associated with depression in a study of older 
adults44.  In a study of children, the ADHD PRS was positively associated with any anxiety or 
depressive disorder but there were some nonsigificant associations for specific disorders 
dependent on the type of diagnostic tool that was used63. In terms of trajectories of depression 
across ages 10-18 years in youth, the higher scores on the ADHD PRS associated with an 
early-adolescence–onset depression class but not late-onset depression62. The ADHD PRS 
also positively associated with a range of eating disorder traits in youth61.  
Neuropsychological constructs. Of the six studies on neuropsychological 
constructs64,33,65,36,52,37 , five included working memory and all reported significant 
associations between poorer working memory and higher ADHD PRS. Other 
neuropsychological constructs studied in relation to the ADHD PRS were executive function 
outcomes (all nonsignificant); vigilance/arousal (significant negative association); output 
speed, mental clock and response inhibition (all nonsignificant); focused attention and delay 
discounting (significant). Three studies used the neuropsychological variables such as 
working memory as mediators in models of the association between the ADHD PRS and 
ADHD36,37,65 (see Table 1). 
Physical health. Of the four studies exploring physical health32,50,35,44 , three included 






































































methods, see Table 1).  The other physical health phenotypes studied were height44 (mixed 
evidence), hypertension and blood cholesterol32 (no associations for either in PRS group 
comparisons).  
Socio-economic Status (SES). Four studies35,41,58,66 tested whether the PRS associated 
with variables related to socioeconomic status. All studies showed a significant association 
with the ADHD PRS being negatively associated with SES. The study by Selzam et al35. 
showed a significant negative association with SES in both their between and within family 
design. 
Other (uncategorized) outcomes. In terms of the nine uncategorized 
outcomes29,35,41,42,49,58,67,68,69, the ADHD PRS was positively associated with being bullied69, 
bullying chronicity69 and a victimization adversity scale58, a total adversity scale58, earlier age 
of onset of bipolar disorder29, reduced participation in research studies68, selected methylation 
probes, reduced parental monitoring, and risk of parental mental disorder or substance use 
disorder41. The ADHD PRS did not associate with infant neuromotor functioning46, 




Table 2 shows the items of the quality assessment (QA), and Table 3 the levels of 
evidence.  The results of the QA for each study are presented in Table 4. Three studies had 
two biases, and five studies had one bias, leaving 36 studies without any notable bias. Studies 
that did have one or two biases were randomly distributed across categories. Item K 
(correction for age, gender, and socio-economic status) was rated most often as -/+ since the 
majority of studies did not correct for socio-economic status and this criteria was not relevant 






































































studies n< 500 which we considered small, although expected effect sizes may differ between 
outcome measures.  
The criteria from the best-evidence synthesis (Table 2) suggested that the evidence for 
an association between the ADHD PRS and the following outcome categories was ‘strong’: 
diagnosed ADHD, ADHD traits, brain-based imaging phenotypes, education, externalizing 
behaviors, neuropsychological constructs, physical health and socioeconomic status.  The 
criteria from the best-evidence synthesis (Table 2) suggested that the evidence was 
‘inconclusive’ for the addiction, autism and autistic traits and mental health categories.  The 
‘Other’ category was not included in the best-evidence synthesis.  
 
INSERT TABLE 2 
INSERT TABLE 3  




Overall, our literature review demonstrates that the ADHD PRS is reliable, robust, and 
operates in a dose dependent manner.  We found strong evidence from our best-evidence 
synthesis that the common genetic variants underlying ADHD, as captured by the ADHD 
polygenic risk score, associated with not only diagnosed ADHD but also with more 
dimensional ADHD traits, more externalizing behaviors, impaired working memory and 
education attainment, reduced brain volume, higher BMI and reduced SES.  These findings 
illustrate that the well-known phenotypic associations between ADHD and many of these 
phenotypes, stemming from decades of research in epidemiology and developmental 
psychology, may partly be explained by shared genetic effects. There is an emerging 






































































suggesting outcomes beyond childhood, such as addiction and adult mental health, may also 
associate with the ADHD PRS. Some phenotypic outcomes are less researched than others; 
this led to quite broad outcome categories in some instances (e.g., physical health) whereas 
others were able to be more specific because of the larger literature (diagnosed ADHD; 
ADHD traits, externalizing behaviors and addiction).  
 
 
The ADHD PRS appears to carry a degree of specificity both in relation to other PRS’s, in 
terms of the wider context of neurodevelopment and mental health, and in its capacity to 
significantly associate with only ADHD-relevant phenotypes. Illustrating this, some studies 
used a multi-PRS model and found that the signal from the ADHD PRS remained significant 
when controlling for other PRS’s60,69 ,62. In the wider context of neurodevelopment and mental 
health, the ADHD PRS often did not associate with other conditions such as autism and 
schizophrenia73,59,31,44 or family history for mental health conditions62, 58,  and it only 
associated with bipolar disorder when it co-occurred with ADHD29. When studies included 
negative control traits they invariably did not, as predicted, associate with the ADHD 
PRS33,44. Yet, there were also some surprising and novel cross-disorder findings: for example, 
the ADHD PRS was associated with eating disorder traits in adolescents61. However, note that 
the effect sizes of these eating disorder trait associations (.10-.13%) were at least five times 
lower than the lowest estimated effect size for ADHD PRS associating with ADHD traits 
(0.7%, the range being 0.7-3.3%). Thus, the literature supports the validity of the ADHD 
PRS: the most consistent and strongest associations were with diagnosed ADHD and ADHD 







































































As a literature, the use of the ADHD PRS is fast growing (44 studies in under three years), of 
high quality (as indicated by our QA assessment), with both breadth -- in terms of the wide 
range of outcome phenotypes --, and depth -- in terms of both replication within and between 
studies and extensive analytic protocols.  Risk of false positives in PRS studies is potentially 
high from a combination of authors being free to pick multiple significance thresholds on 
which to test associations and multiple phenotypes. Most studies appeared to have clear 
measures in place to avoid false positives: as noted in Table 1, the majority employed some 
form of significance criterion correction and stated their SNP-based significance thresholds 
(pT), most selected a single pT and provided a justification for their choice, and many 
included sensitivity analyses to ensure results were robust. Common sensitivity analyses 
included repeating analyses on other pT, on different ancestral groups within the sample, 
excluding children on medication and in community samples by excluding diagnosed ADHD 
children.   
 
Within the studies on non-ADHD disorders, the ADHD PRS appears useful for predicting 
trajectories. Specifically, the ADHD PRS appears to have transdiagnostic utility in 
characterizing subgroups of individuals with early onset symptoms in non-ADHD conditions. 
For example, while ADHD PRS did not associate with schizophrenia, within a schizophrenia 
sample it associated with cognitive trajectory from adolescence into adulthood, being most 
strongly associated with the subgroup with (earliest) preadolescent cognitive impairment54. 
The ADHD PRS did not associate with bipolar disorder, but it associated with an earlier age 
of onset within bipolar disorder cases29. Finally, the ADHD PRS associated with an early 
onset depression trajectory class but not a later-onset depression trajectory class in youth 







































































The ADHD PRS has been used in several studies to investigate gene-environment correlation, 
namely, genetic influences on environmental exposure. Direct effects of the ADHD PRS are 
reported on lower socioeconomic status35, lower parental education and income41, worse labor 
market outcomes66, adversity58 and bullying victimization69,58.  Two studies went beyond 
direct genetic effects by applying within family analytic designs.  De Zeeuw et al (2019) split 
the ADHD PRS into transmitted and nontransmitted alleles to test for a process termed 
“genetic nurture”34,122. They did not find that the parents’ nontransmitted ADHD PRS (the 
part of the ADHD PRS inherited by parents but not transmitted to their offspring), influenced 
the offspring’s ADHD symptoms. Selzam et al’s more elaborate design involved splitting up 
the covariance within their sample of twin siblings into between-family and within-family 
effects35.  They conclude that some of the association between the ADHD PRS and 
educational attainment might be due to passive gene-environment correlation effects. It is 
important to note going forwards that part of the signal in a PRS may be correlated with 
socioeconomic factors.  
 
 
The reviewed literature included multiple studies investigating PRS-brain-behavior pathways 
relevant to ADHD.  This new literature is worth highlighting in part because most attempts 
pre-GWAS to link neuroimaging data simultaneously to both genetics and behavior was a 
noble failure, beset with issues of multiple testing and low power123,124. The studies in our 
review demonstrate that reduced brain volume mediates the association between the ADHD 
PRS and ADHD. For example, in one recent study, the ADHD PRS was negatively associated 
with total brain volume and total brain volume accounted for 16% of the association between 
ADHD PRS and ADHD diagnosis49. Mediation was also employed successfully in other 






































































ADHD PRS and ADHD diagnosis was mediated by working memory and arousal alertness 
latent variables. In the externalizing category, it was shown that externalizing symptoms 
mediated the association between the ADHD PRS and adversity58.  
  
 
The ADHD PRS can teach us about the core aspects of ADHD and its nosology.  Eventually, 
the ADHD  PRS may contribute to the clinical picture for individual patients, but due to the 
current small effect sizes, the ADHD PRS is useful for research purposes only.  Given the 
presence of the three presentations of ADHD in the DSM-5 (combined, predominantly 
inattentive, predominantly hyperactive-impulsive), it is perhaps surprising that only four of 
the 16 studies on ADHD traits investigated associations of the ADHD PRS separately by 
ADHD symptom domain38,33,39,36. Another study that touched on nosology proposed that 
emotional dysregulation should be considered a core component of ADHD, in light of their 
finding that an ADHD subgroup with emotional dysregulation had a higher ADHD PRS score 
compared to other ADHD subgroups55.   
 
Given the variety of outcome categories, and variety of outcome measures within categories, 
a meta-analysis was not conducted. Still, we report the current range in effect sizes for ADHD 
and ADHD traits. Furthermore, to obtain insights into the reliability and strength of the 
associations, we applied a best-evidence synthesis that was based on a careful and systematic 
quality assessment of all studies. Other limitations of our systematic review include the fact 
that it is difficult to estimate the power of studies based on their target sample size without 
knowing the expected effect size of an association125.  We restricted our review to studies 
employing PRS based on the largest and latest GWAS on diagnosed ADHD. This meant 






































































diagnosed ADHD (e.g., 126) and studies using older ADHD PRS (e.g. reviewed by 33) and 
studies using a cross-disorder PRS that includes the ADHD PRS. Not all of the 44 studies are 
completely independent due to some partially or completely overlapping samples.  For most 
categories, every study was based on a different sample. However, it should be noted that 
three of the 10 studies on mental health outcomes used the ALSPAC sample and two used the 
CATSS sample. However, given that the evidence for the mental health category was mixed 
and inconclusive, the repeated use of the ALSPAC and CATSS sample in this category does 
not appear to have inflated the consistency of the evidence for these categories. In terms of 
the other categories, two of the 16 ADHD trait studies and three of the eight studies on brain-
based outcomes employed the IMAGEN sample and two of the eight addiction studies 
employed the Add Health sample.  Lastly, we included studies based on clinical, enriched, 
and population-based samples. We found no differences between the samples in their 
associations with the outcome measures: In the outcome measures for which we observed 
inconclusive results, (i.e., autism, addiction, and mental health) significant associations did 
not cluster by sample type. 
 
While emphasizing the high quality of most of the reviewed literature and the strong evidence 
that has emerged for associations of the ADHD PRS with outcomes, a number of limitations 
and suggestions for improvements in this field of research are noted.  Ideally, field standard 
approaches in terms of the method of analyzing PRS’s would be devised and pre-registration 
is essential. At present, there are multiple approaches and methods which are only beginning 
to be formally compared127. The selected pT and the justifications for selection of pT varied 
widely across studies: some selected p<.05 to avoid over-fitting, some selected the pT that 
most accurately predicted ADHD in Demontis et al17, some use pT=1 to capture all variance, 






































































threshold, we had to select one from which to report the results and this may exacerbate false 
positives. A reference-standardized approach may be needed to compare PRS across different 
target samples, to avoid factors often specific to the target sample influencing PRS, including 
the variants considered, LD and allele frequency estimates127.  It will be exciting to see future 
work that combines the ADHD PRS with rare variation and copy number variation or that 
incorporates the sex chromosomes.    
 
As shown in Table 1, the majority of this literature was conducted on European ancestry 
samples: of the 44 studies, 77% (n =34 studies) had European ancestry, 91% (n = 41) had 
most or all European ancestry, one study had missing ancestry and 5% (n=2) had non-
European ancestry participants (Japanese and African American, respectively). To maximize 
the value of the data, some studies ran sensitivity analyses on their samples based on different 
ancestral populations32,65. Major initiatives in terms of both sample ascertainment and method 
development are needed to ensure the genetic architecture of ADHD is understood regardless 
of ancestry of the population under study128. At present, the literature on the ADHD PRS only 
offers partial insight globally because roughly only one in twenty studies on the current 
ADHD PRS to date employs non-European ancestry participants. 
 
It is noted that some of the associations identified here are largely supported by studies 
employing LD score regression as well as from past twin studies. LD score regression 
provides an estimate of the degree of shared genetic effects in common genetic architecture. 
PRS studies are distinguishable for several reasons, including that they allow tests for 
association between ADHD and other phenotypes that currently lack a large GWAS. 






































































analytic frameworks to test more complex hypotheses, such as analyses involving trajectory 
modelling or mediation models. 
 
In terms of individual prediction, the existing literature only goes so far as to compare groups 
scoring high, medium and low on the ADHD PRS in a small number of our reviewed studies. 
The ADHD PRS cannot yet accurately predict individual outcomes, and a PRS is only as 
accurate as the discovery sample from which it is computed.  Anyone who has used direct-to-
consumer testing can upload their genetic data on a new tool to calculate their own ADHD 
PRS129. Most individuals who score high on the current ADHD PRS will not develop ADHD 
because the signal is too weak. There is a strong need for public engagement and public 
debates on the clinical usability of PRS130.  It is possible that a more predictive ADHD PRS 
will be used in the future, in combination with other known risk factors and clinical features, 
to support health services with prediction, diagnosis and intervention131. As pointed out 
elsewhere, there are some similarities between existing successful health screening practices -
- such as the newborn APGAR score and neonatal blood spot screening -- with how a PRS 
would be obtained and could work in practice19.  
 
In sum, our review identified 44 relevant studies and demonstrates that strong evidence has 
accumulated that the ADHD PRS associates with not only ADHD and ADHD traits, but also 
reduced brain volume, lower education attainment, more externalizing behaviors, impaired 
working memory, higher BMI and lower socioeconomic status. Alongside these direct effects, 
the ADHD PRS is being used to reveal more complex processes such gene-environment 
correlation and that the ADHD PRS influences ADHD symptoms via effects on brain 
structure.  Genetic associations that might have been expected based on past literature, such as 






































































from the available evidence.  In the context of other known risk factors for ADHD, the 
ADHD PRS does not have the largest effect size. Nevertheless, the ADHD PRS brings 
advantages in terms of being based on genetic variants, and thus being biologically-based, 
possessing a degree of causality and being unchanging across the lifespan (unlike most other 
risk factors).  The estimated SNP heritability of ADHD is larger than the percent variance 
explained by the current ADHD PRS. We can expect, therefore, that with a larger GWAS of 
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Table 1: Description of included studies 
Category Study 
 







































MRI:  neuroanatomic 
imaging, and imaging of 
white matter tract 
microstructure correlates of 
ADHD symptomatology  
ADHD traits: composite 
score of the Development 
and Well-Being 
Assessment (DAWBA)70 
and the Strengths and 
Difficulties Questionnaire71 
(SDQ)  
Covariates: Age, sex, site, 
socioeconomic status, 
pubertal stage, total brain 
volume, PCs 
ADHD PRS was significantly associated with ADHD traits in 
participants with available cortical thickness data (r = 0.125, p < 0.001), 
and with available diffusion data (r = 0.137, p < 0.001).  
ADHD PRS predicted neuroanatomic imaging, and imaging of white 
matter tract microstructure as it significantly associated with the ADHD 
dimensional symptom score (b = −0.044, p = 0.045). Sex did not 
significantly moderate the association between PRS score and mean 
FA.  
Repeated analyses with the PRS SNP threshold changed to p < 0.01 
and <0.10 showed consistent results, as did repeated analyses 
controlling for IQ.  
In voxel-wise analysis within white matter skeleton regions, the 
neuroanatomic imaging, and imaging of white matter tract 
microstructure association was significantly associated with ADHD 
traits. Strongest associations (p < 0.001, uncorrected) were revealed in 
portions of the left inferior fronto-occipital, superior longitudinal and 
inferior longitudinal fasciculi.  
ADHD PRS not associated with cortical thickness in the cortical areas 
that were significantly associated with ADHD traits  
Table
 2 
Statistical thresholds were p<.05 family-wise error corrected and brain 


















204 with mild 
TBI; 79 with 

















Mild traumatic brain injury 
(TBI), and ADHD 
symptoms.  
Structured interview 
assessed symptoms and 
criteria corresponding to 
ADHD diagnostic criteria 
ADHD (Diagnostic and 
Statistical Manual of Mental 
Disorders, fifth edition 
(DSM5)72) 
Covariates: age, sex, 
parental education, PCs 
A significant interaction between ADHD PRS and group (mild TBI 
versus no TBI) (t1427 = -2.1, p = .04). ADHD PRS showed a positive 
association with ADHD symptom score in youths without TBI (t1224 = 
3.5, ' R2 = .009%, p = .004) and no association with ADHD symptom 
score in those with mild TBI (t196 = 20.4, ' R2 = 2.004%, p = .70).  
 
Sensitivity analyses were run excluding individuals with ADHD and 
individuals taking medication for emotions or behavior issues.  Both 
these analyses showed a similar interaction pattern but the interaction 
did not reach significance. 
 






























only and ADHD 
only samples 
















(0.01 - 1)  
DSM-IV74 ADHD diagnosis, 
ASD diagnosis, and 
combined( either ASD, 
ADHD or both diagnoses)  
Parent-rated Child Behavior 
Check- list/6–18 (CBCL)75.  
Covariates: Age, PCs 
 
ADHD PRS predicted both the combined (ADHD and/or ASD) 
diagnoses (OR 1.28; p = 1.3 × 10−3)and ADHD-only (OR 1.4; p = 3.6 
× 10−4), but not ASD-only.  At the most optimal p-value threshold, R2 
= 0.02% for the combined (ADHD and/or ASD) sample and R2 = 
0.045% for the ADHD-only sample.  
Planned sensitivity analyses between ADHD symptom severity scales 
and PRS were not run due to low correlations. 
Significance threshold was p<.05 Bonferroni corrected for 72 tests.  
 4 
17-79 years, 
























































ADHD diagnosis based on 
retrospectively self-reported 
ADHD symptoms keyed to 
the DSM-IV74. 
Lifetime DSM-IV criteria for 
alcohol abuse or 
dependence were assessed 
as the presence of at least 
1 of the 4 items pertaining 
to alcohol abuse, and/or 3 
of the 7 items pertaining to 
alcohol dependence 
occurring together in 12-
month period. 
Educational attainment, 
measured by the question 
‘what is the highest level of 
education that you have 
achieved to date?’. Scale 
ranged from 1 (‘8th grade or 
less’) to 10 (‘some graduate 
training beyond a master’s 
degree’).  
Cognitive ability, measured 
by Add Health Picture 
Vocabulary Test (AHPVT)76.  
ADHD PRS was associated with ADHD diagnosis (OR 1.22, p < 
0.001). In terms of probability of ADHD by PRS group, PRS low = PRS 
medium < PGS high and PRS low<PRS high at p<.005. 
Overall significant group differences (comparing high, medium, low 
PRS groups) were reported for all outcomes except alcohol 
abuse/dependence rates, hypertension, or on high-blood cholesterol 
(at p<.005). 
Low and high ADHD PRS groups differed significantly (after 
Bonferroni correction) on all outcomes with exception of alcohol 
abuse/dependence rates, hypertension, or on high-blood cholesterol.  
In some cases, the low PRS group differed significantly from the 
medium PRS group, suggesting a protective role for low PRS scores. 
Low PRS group had higher cognition and education attainment and 
lower BMI than medium PRS group. These same variables 
significantly distinguished the medium and high PRS groups, as did 
drug abuse/dependence, ever being arrested and perceived stress.  
Bonferroni corrected significance threshold of p<.005 applied 
throughout.  
 
Secondary analyses demonstrated consistent results in European-
ancestry subsample of total sample. 
 5 
Mental health, measured by 
diagnoses based on the 
DSM-IV74, the Center for 
Epidemiologic Studies 
Depression (CES-D) 
Scale77, and an abbreviated 
4-item version of the 
Cohen’s Perceived Stress 
Scale78. Also, it was asked 
whether participant was 
‘ever arrested’.  
Physical health determined 
based on body mass index 
(BMI) and patients reported 
if they had hypertension or 
high blood cholesterol as 
reported by a doctor.    
Covariates: age, sex PCs 
















11.0 years SD: 
2.8). Of total 








Strengths and Weaknesses 
of ADHD Symptoms and 
Normal Behavior Rating 
Scale (SWAN) score79: 
Total, inattentive and 
hyperactive/impulsive 
subscales.    
 
Divided sample into low, 
medium and high SWAN-
scoring groups (low: z-score 
<-1.11, n = 670; medium: z-
score -1.11 to 1.11, n = 
3,745, and high: z-score 
<1.11, n = 739). Also 
categorized sample using 
cut-off identified in ROC 
ADHD PRS was significantly associated with SWAN total score (b= 
.005, p = 1.7 x 10-11, R2 = .009), separately for parent-report (b= 
.0045, p = 9.0 x 10-9, R2 = .009) and self-report (b= .042, p = 6 x 10-4, 
R2 = .016) and separately for inattentive (b= .004, p = 1.6 x 10-10, R2 
= .008) and hyperactive/impulsive subscales (b= .004, p = 1.3 x 10-9, 
R2 = .007). The association with the total score was still significant 
after excluding individuals with an ADHD community diagnosis.  
Comparisons of ADHD PRS in the categorized SWAN-scoring groups 
showed low<high, medium<high but low=medium. 
ADHD PRS was also significantly higher when comparing groups 
scoring above versus below the optimal cut-off identified in ROC 
analyses for parent-reported SWAN and using the Swanson cut-point 
of z-score >1.65. The self-rated subsample did not show a significant 
difference between groups. 










analyses and published cut-
off of z-score>1.65. 
 

























based on 12 
pT (0.01 - 1)  
 
Diagnoses based on school 
history of reading problems, 
word reading tests, or 
dyslexia diagnosis. 
Eight outcomes relating to 
word reading, spelling, 
rapid naming, and 
phonology that are 
considered core deficits in 
dyslexia: Word reading 
(WRead), nonword reading 
(NWRead), and word 
spelling (WSpell), Phoneme 
awareness (PA), digit span 
(DigSpan, a measure of 
verbal short-term memory), 
and 
rapid automatized naming 
of letters (RANlet), digits 





ADHD PRS was negatively associated with WRead, Wspell, and 





ADHD PRS was not significantly associated with the other 5 
outcomes.  
A significance threshold of 6.94 x 10−5 .was applied to correct for 









Six later-life US labor 
market outcomes: currently 
working for pay, individual 
ADHD PRS was significantly associated with all six labor market 
outcomes. One SD increase in ADHD PRS associated with decrease 



















earnings (gross individual 
income), total household 
wealth (net value of total 
wealth, excluding second 
home, if applicable), 
receiving governmental 
assistance in the form of 
social security disability 
insurance, receiving 





included as mediator and 
measured by years of 
education.  
Covariates: sex, age, 
marital status, number of 
living children, self-reported 
health, whether health limits 
work, tenure in current 
occupation, log of spousal 
earnings, PCs 
income (15.80%), lower household wealth (12.98%). Higher ADHD 
PRS associated with increased likelihood of receiving social security 
disability benefits (20.56% higher odds), receiving unemployment or 
worker compensation (6.72% higher odds), and receiving 
governmental transfers (27.38% higher odds).  
For all six outcomes, some of the association was reduced when 
educational attainment was added as a mediator. 
Most results were highly consistent when split by sex and when split 
by assessments conducted at ages 50-55 and 50-59 years.  























Gambling behavior and 
disordered gambling  
The two phenotypes were 
categorical: answering yes 
or no to “Have you ever 
bought lottery tickets, 
played video games or slot 
machines for money, bet on 
horses or sporting events, 
or taken part in any other 
kinds of gambling for 
ADHD PRS was not associated with either gambling behavior or 
disordered gambling.  
 




































money?”; and (if yes to the 
previous question), answer 
of yes or not to: “Has your 
gambling ever caused 
serious financial problems 
or problems in your 
relationships with any of 
your family members or 
friends?”  













referred to a 
specialized 


























Diagnosis based on Autism 
Diagnostic Observation 
Schedule (ADOS), and/or 
the Autism Diagnostic 
Interview-Revised (ADI-R) 
Three executive function 
outcomes from the 
Behavior Rating Inventory 
of Executive Function 
(BRIEF)80, a 86-item 
questionnaire.  The 
Behavior Regulation Index 
(which incorporates 3 
subscales: inhibit, shift, and 
emotional control) and the 
Metacognition Index (which 
incorporates 5 subscales: 
initiate, working memory, 
plan/organize, organization 
of materials, and monitor).  
The Global Executive 
Composite Index comprised 
all 8 above subscales. 
Social function was 
assessed using the Social 
Responsiveness Scale, a 
65-item questionnaire81.  
Covariates: age, sex, PC’s 
ADHD PRS not associated with the any of the executive function 
outcomes or the autistic trait scale in a regression or when comparing 
high versus low ADHD PRS scoring groups (those in the top and 
bottom 15% of the PRS distribution, respectively). 
 


















(5x10-8 - 1)  
 
A diagnostic evaluation 
using standardized, well-
normed rating scales from 
parent and teacher, parent 
semistructured clinical 
interview, child intellectual 
testing, and clinical 
Using a structural equation model, it was shown that the ADHD PRS 
was associated with ADHD severity (b = .171, 95% CI = 0.085–0.258; 
' R2 = .029, p < .0001), irritability (b = .183, 95% CI = 0.087–0.280; ' 
R2 = .034, p < .0002) and also with surgency/sensation seeking (B = 
.146, 95%CI = 0.052–0.240, 'R2=.022, p = .002). These associations 




















research diagnoses and 
final eligibility were 
established by two 
experienced clinicians (a 




Dimensional score on an 
ADHD latent variable 
captured from hyperactivity 
and inattention subscales of 
four published ADHD 
scales.  
Irritability captured with 
latent variable based on two 
subscale scores: anger and 
modified soothability from 
the Temperament in Middle 
Childhood Questionnaire 
(TMCQ)82 and an 
oppositional defiant 
disorder irritable total 
score83. 




A person-centred approach 
compared different group 
definitions of ADHD with 
anxiety scores and their association with ADHD. The ADHD PRS was 
not associated with the sadness/anxiety latent variable. 
In the person-centred analyses (i.e. looking at ADHD subgroups), the 
ADHD PRS was elevated in the ADHD versus not ADHD group (OR = 
1.43, 95% CI = 1.17–1.75, 'R2 =.033 p = .0004). The emotion 
dysregulation ADHD group had elevated ADHD PRS versus other 
ADHD children (OR = 1.44, 95% CI = 1.03–2.20, Nagelkerke ' R2 = 
.013, p = .033) but the ADHD PRS did not differentiate irritable or 
other ADHD profiles.  
All effects were independent of variation in ADHD severity across 
traits or groups. Sensitivity analysis suggested changes in latent 
variable indicators or covariate handling did not influence results. 
Significance threshold of p<.01 was applied. 
 11 
and without irritability and 
emotion dysregulation 
Covariates: sex, age, 
lifetime mood disorder and 
PCs 
EA, MH 11. 
Dickinso











mean age 34.1 
years (10.1 sd). 
24.6% female, 
75.4% male  
247 siblings 
with no history 
of psychotic 
disorder 












based on 10 
pT reduced 












schizophrenia and their 
siblings were assigned to 
one of 3 clusters based on 
trajectories of cognitive 
development: cognitively 
stable (CS), adolescent 
decline (AD), preadolescent 
impairment (PI). 
Wide-Range Achievement 
Test [WRAT] reading 
subtest85 and Wechsler 
Adult Intelligence Scale 
[WAIS]86 used for cognitive 
assessments. 
 
Covariates: sex, age, PC’s 
 
The ADHD PRS did not differ significantly between schizophrenia 
patients, siblings and controls.  
 
Within the participants with schizophrenia, the ADHD PRS showed 
significant association with cognitive trajectory group (F=5.1 df = 2,525 
p = 0.007, R2 = 0.019%). Pairwise comparisons showed PI>AD=CS 
(at p<.05). 
 
Within the siblings, the ADHD PRS did not show a significant 
association with cognitive trajectory group (F=0.3 df = 2,232) and no 



































Cocaine dependence, as 
measured by the DSM-IV74. 
ADHD-PRS was significantly associated with cocaine dependence 
(pseudo- R2=1.39%, p =4.5e-17).  
SNP threshold of p<5.7e-04 applied to account for multiple testing 
 







Project, Japan  





based on six 
pT (0.01-1) 
Schizophrenia (based on 
the criteria of the DSM572) 
or being a first degree 
relative of someone with 
schizophrenia. 
 
ADHD PRS were not significantly different between all the groups 
(patients with schizophrenia, their first-degree relatives and controls) 
or between any pairwise comparisons at p<.01. 






mean age: 42.9 









mean age: 59.7 




mean age: 37.2 























based on pT 
= 0.5  
 
Diagnosis by Conners' 
Rating Scales-3rd Edition 
short form, Strengths and 
Difficulties Questionnaire 
long form including the 
impairment module (SDQ), 
the ADHD Rating Scale 
ADHD-RS 
 
ADHD PRS was negatively associated with TBV [β = −0.147 (−0.27 to 
−0.03)] and this remained significant after controlling for ADHD 
diagnosis.  
 
TBV accounted for 16% of the association between ADHD PRS and 
ADHD diagnosis after accounting for sex and age.  
 

















MRI: Total brain volume 
(TBV) and subcortical 
structures  
 
Covariates: motion during 
MRI scan, PCs, age, sex, 
average FD (i.e., motion 
during the scan [average 
framewise displacement]), 
sex interaction effect, 
diagnosis. TBV also a 
covariate in analyses on 
subcortical structures 
Among females only, the ADHD PRS was significantly associated with 
increased putamen volume [β = 0.224 (0.09– 
0.36)].  
 






















age range 7-18 
years, mean 
age: 11.5, SD: 
3.1 years. 
Clinical sample 










based on 10 
pT 
DSM-IV74 Axis 1 diagnoses; 
a range of parent-rated 
dimensional published 
scales of psychopathology 
Somatic complaints 
measured with the CBCL75 
Social cognition measured 
with the SRS81 
IQ and working memory 
from the Wechsler 
Intelligence Scale for 
Children–Fourth Edition for  
7- 16-year-olds and the 
Wechsler Adult Intelligence 
Scale–4th Edition 17-18 
year  olds. 86 87  
Academic achievement with 
the Word Reading and 
Numerical Operations of the 
Wechsler Individual 
In this clinical sample including a wide mix of psychiatric diagnoses, 
ADHD PRS was associated with broad ADHD diagnosis (OR 1.44, 
95% CI 1.14-1.81; Pseudo R2 2.01; permuted p .0011) as well as 
ADHD traits (b = 1.46; R2 = 2.93%; F = 11.83, permuted p = .0007) 
and with Hyperactivity/Impulsivity subscale (b = .97; R2 = 2.00%; F = 
8.81, permuted p = .0063) but not with Inattention. 
For non-ADHD outcomes, the ADHD PRS predicted word reading (b 
= -2.11; R2 = 2.05%; F = 8.68, permuted p = .0043) and numerical 
operations (b = -2.20; R2 = 2.27%; F = 9.25, permuted p = .0030). 
ADHD PRS was also associated with aggressive behavior (b = 1.58; 
R2 = 2.59; F = 10.52, permuted p = .0019) and working memory 
index (b = -2.17; R2 = 2.47; F = 10.10, permuted p = .0016). 
Controlling for ADHD and stimulant use did not change the above 
non-ADHD outcome findings. 
ADHD PRS did not significantly predict somatic complaints measured 
with the CBCL 75or social cognition measured with the SRS81, 
considered to demonstrate discriminant validity of the ADHD PRS. 
Results are reported for the most significant pT. 
The adult psychiatric sample showed similar results, ADHD PRS was 











year old adult 








The adult replication cohort 
outcomes were ICD-10 
ADHD, whether education 
was completed by age 23 
years or not, and presence 
of substance use disorder 
history.  
Covariates: age, sex, 
genotyping wave (in 
biobank analyses), PCs  
 
 
Pseudo R2 0.42%, p = .0028) reduced likelihood of college 
completion (OR 1.23, 95% CIs 1.12 – 1.35, Pseudo R2 0.72%, p 
<.0001) and substance use disorder (OR 1.18, 95% CIs 1.10 – 1.26, 
Pseudo R2 0.40%, p <.0001).  
Division of youth sample into high (>30%), medium (middle 40%) and 
low (<30%) PRS scoring groups showed that the high group had a 
more severe multivariate pattern of psychopathology compared to the 
low group (b = .21, p =.01). No significant differences between the 
medium and low groups. 















age 7-12 (wave 
1) age range 
18-32 years 








Latent classes were derived 
for externalizing behaviors 
(which included aggressive 
behaviors, non-aggressive 
rule breaking and 
substance use behaviors) 
assessed at Waves 3 and 4 
by in-person interviews. 
4 mediators selected from 
wave 1 assessment: 
Supportive parenting, 




closeness assessed in 
relation to 10 named friends 
ADHD PRS correlated .084 with ADHD symptoms (p<.01) 
ADHD PRS predicted 17.0% increased odds in the High Decreasing 
(OR = 1.17 95% CI = 1.002, 1.366, p=.05) and 8.0% increased odds 
in the Moderate (OR = 1.08, 95% CI = 1.004, 1.163, p=.03) 
externalizing trajectories, but was not associated with the Low 
Increasing (95% CI = 0.868, 1.265) trajectory, relative to the Normal 
trajectory group.  
There was no longer evidence of direct associations between ADHD 
PRS on externalising trajectory groups relative to the Normal 
trajectory group once mediators were added to the models. School 
connectedness either partially or fully mediated the effects. 













retrospectively with DSM-IV 
items at Wave 3. 
Covariates: PCs, sex, age, 




































Growth mixture modelling 
gave 5 distinct irritability 
trajectory classes: low, 
decreasing, increasing, 
late-childhood limited, and 
high-persistent  
 
Parent-reported data on 
irritability from the 
oppositional defiant 





interview—at ages 7, 10, 13 
and 15 years. 
 
DAWBA also used to 
diagnose ADHD, 
oppositional defiant 
disorder, conduct disorder, 
generalized anxiety 
disorder and depression 
ADHD PRS was associated with an increased likelihood of being in 
both the high-persistent (odds ratio=1.31, 95% CI=1.09–1.58, 
p=0.005) and the increasing (odds ratio=1.28, 95% CI=1.11–1.48, 
p=0.001) trajectory classes relative to the low irritability trajectory 
class. The odds were similar for being in either trajectory (high-
persistent compared with increasing trajectory class: odds ratio=1.02, 
95% CI=0.81–1.29, p=0.854). The ADHD PRS did not predict being 
in the decreasing or late childhood limited trajectory groups.  
Results were consistent when sex was controlled for and when 
individuals with diagnoses were excluded. PCs were not controlled 
for. 




















(BP) cases (all 
BP type 1) 
(60% female; 










472 BP cases 
with childhood 
ADHD data 
(67% BP type 





















Bipolar disorder in the UK 
sample was assessed using 
the ICD-10, and in the 
Romanina sample with 
DSM-IV74 criteria, based on 
Diagnostic Interview for 
Genetic Studies (DIGS) and 
medical records. 
Childhood ADHD within BP 
cases was assessed 
retrospectively using the 
Wender Utah Rating Scale 
(WURS)89 and for some 
Romanian cases also using 
items from the Kiddie-
SADS90 clinical interview. 
Assessment of childhood 
ADHD was made by 
clinicians. 
Earl- and late-onset BP 
defined as age of onset 




ADHD PRS differentiated BP cases with childhood ADHD from 
controls in the meta- analysis of both samples (OR = 0.2 (0.08–0.32) 
z =3.23, FDR-corrected p = 0.024).   
The ADHD PRS differentiated BP cases with childhood ADHD from 
BP cases without childhood ADHD in the meta-analysis but this did 
not survive FDR-correction (OR = 0.18 (0.04–0.31) z = 2.55 p = 
0.011 FDR-p = 0.055).  
ADHD PRS associated with the continuous measure of ADHD 
symptoms (based on WURS and Kiddie-SADS) within the BP cases 
in the meta-analysis (b = 1.7 (0.7–2.69) z = 3.34 p = 0.0008 FDR-
corrected p = 0.024). This result remained when sex or BP age of 
onset were included as covariates. This association was found to be 
driven by BP cases with early onset (<22 years). 
ADHD PRS did not differentiate all BP cases from controls at either 
nominal or FDR-corrected significance (OR=0.085, (0-0.17) z = 1.95, 
p = .051, FDR-corrected p = .105). However, it did differentiate early-
onset BP cases from controls (OR = 2.51 (1.04–3.97), z =3.36, p 
=0.0008, FDR-corrected p = 0.024) but not late onset cases.  
ADHD PRS predicted earlier age of onset within BP group (b=-.92, (-
1.61--0.23) z = -2.62, p = .009, FDR-corrected p = .049). 
Results given here for most significant PRS pT. 































Median age at 
first SUD 
diagnosis was 
















At least one substance use 
disorder (ICD‐8 and ICD‐
10‐Diagnostic Criteria for 
Research (DCR)23) in 
Danish registers after 13th 
birthday. Categorized by 
type into alcohol, cannabis, 
and other illicit drugs and 
second categorized into 
severity into use, abuse and 
addiction. Nicotine use not 
included.   
 
Other known SUD risk 




parental SUD, parental 
mental disorder, paternal 
income, maternal 
education, obtained from 




time (to account time at risk 
for SUD given varying ages 
of participants), sex, age 
and calendar 
ADHD PRS were associated with any SUD (OR = 1.30, 95% CI: 
1.11–1.51; Nagelkerke R2= .14). For types of SUD, associations were 
observed for alcohol (OR = 1.26, 95% CI: 1.04–1.53), cannabis (OR 
= 1.34, 95% CI: 1.10–1.64) but not illicit drugs (OR = 1.21, 95% CI: 
0.99–1.50). For severity of SUD, associations were observed for use 
(OR = 1.36, 95% CI: 1.02–1.80), addiction (OR = 1.30, 95% CI: 1.07–
1.57) but not abuse (OR = 1.21, 95% CI: 0.88–1.65). 
Stratified by sex, the point estimate for the ADHD PRS-SUD 
association was higher in females but CIs overlapped with CIs for 
males.  
 
The other known SUD risk factors were all themselves associated 
with ADHD PRS (at p<.001). Nevertheless, the above SUD 
associations still remained with the ADHD PRS when controlling for 
these known SUD risk factors. 
Sensitivity analyses repeated with different pT, different assumed 
prevalences of ADHD and SUD, and variation in population structure 
showed similar results.  





















year at first ADHD 












n = 5518 at age 
7 years and n = 





















factor for ages 7 and 13 
years 
 
Emotional, behavioral and 
neurodevelopmental 
problems were determined 
with the DAWBA70.  
Additionally, the Social and 
Communication Disorders 
Checklist91 (SCDC) was 
used for social-
communication problems 




ADHD PRS was associated with the general psychopathology “p” 
factor at age 7 (B 0.087, se 0.019, p <0.001), and age 13 (B 0.095, 
se 0.020, p <0.001) while including the above other 3 PRS in the 
models.   
Without other PRS in the model, the ADHD PRS predicted the p 
factor at age 7 (B 0.093, se 0.019, p <0.001, R2 = .009%) and age 13 
(B 0.095, se 0.019, p <0.001, R2 = .009%) 
Results were consistent when the other PRS were excluded from the 
model and analyses repeated using inverse probability weighting to 
address potential bias due missing genetic data revealed similar 




























based on pT 
0.05 
 
BMI derived from height 
and weight measurements 
at age 19 
 
Voxel-based morphometry 
measures of whole-brain 
grey matter at age 19 
 
Neural responses to reward 
anticipation and reward 
outcome from activation 
maps from a Monetary 
Incentive Delay fMRI task at 
age 19 
 
A neural endophenotype 
created which was made up 
of grey matter regions and 
regions of activation derived 
from the fMRI task.  
 
Impulsivity symptoms at 
age 19 assessed using self-
reported Barratt Impulsivity 
Scale (BIS)92. 
 
Covariates: sex, imaging 
site, age, PC’s and total 
intracranial volume 
ADHD PRS correlated with impulsivity symptoms (r = 0.10, p = 0.014 
FWE corrected). 
ADHD PRS was correlated with the neural endophenotype (r = 0.087, 
p = 0.036 FWE corrected).  
In mediation analyses, the ADHD PRS associated via the 
neuroimaging substrate with impulsivity symptoms (b =  0.006, 90% 
CIs =  0.001, 0.019) and BMI (b =  0.009, 90% CIs =  0.001, 0.025). 
Significance levels ascertained from permutation testing, one-sided 













Trios (i.e. one 
offspring and 
both parents). 
















ADHD symptoms (CBCL 
and TRF Attention 
Problems scale75) were 
assessed at age 10 or 12 
years.  
Academic achievement was 
assessed with the Cito 
score, a Dutch nationwide 
standardized educational 
achievement test93 
Educational attainment in 
adults assessed as self-
reported highest degree. 
Covariates: sex, year of 
birth (only for EA), the 
interaction between sex and 
year of birth (only for EA), 
PCs, genotyping platform. 
 
EA PRS and ADHD PRSs correlated for both the transmitted and 
non-transmitted PRS (r = − 0.27 and r  = − 0.23, respectively). 
ADHD transmitted and nontransmitted PRS were not significantly 
associated with academic achievement (R2 ~ 0.6%). ADHD 
transmitted PRS was associated with ADHD symptoms (R2 = 1–2%).  
The transmitted ADHD PGS was associated with ADHD symptoms at 
home (β = 0.17 CIs .12-.21, R2 = 2.7%, p = 2 x 10 -13) and at school 
(β = 0.13 CIs .08-.17, R2 = 1.6%, p = 3 x 10 -7) but not with academic 
achievement (β = − 0.08 CIs -.14--.01, R2 = .6%, p = 0.022).  In a 
model that included both the EA PRS and ADHD PRS, the above 
effects remained between ADHD PRS and ADHD symptoms at home 
and school but the association between ADHD PRS and academic 
achievement was no longer significant. 
The non-transmitted ADHD PGS was not associated with any of 
above three the outcomes.  
Significance threshold of p<.01 employed. 
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Twin Study in 
Sweden 
(CATSS) 
N = 13,472 
participants, 
assessed at 


















Self- reported ED 
symptoms were measured 
by 3 subscales (Drive for 
Thinness, Bulimia, and 
Body Dissatisfaction) from 
the Eating Disorder 
Inventory-2 (EDI-2)94, at 15 
years  
Covariates: sex, birth year, 
and PCs 
ADHD PRS was associated with the EDI-2 full scale (b = .027, 95% 
CI = .005, .049, R2 = .0012%, p = .015) and subscales Drive for 
Thinness (b = .032, 95% CI = .005, .059, R2 = .0010%, p = .022) and 
Body Dissatisfaction (b = .042, 95% CI = .011, .072, R2 = .0013%, p 
= .007) but not the Bulimia subscale (b = .004, 95% CI = -.013, .021, 
R2 = .0000% p = .654).  
Results were consistent at other pT; significant sex differences were 
not significant. 












district in the 
Mid-Atlantic 
region, USA 
N = 1,050 
participants 
56% female, 







based on pT 
< 0.05 
 
To assess past year 
marijuana abuse and 
dependence at age 20, 
Composite International 
Diagnostic Interview-
University of Michigan 
Version (CIDI-UM)95 was 
used in 2 cohorts. In the 
third cohort, National 
Survey on Drug Use and 
Health (NSDUH)96 was 
used.  
The Structured Interview of 
Parent Management Skills 
and Practices Youth-
Version (SIPMSP)97 was 
used to assess parental 
The ADHD PRS correlated negatively with parental monitoring (r = - 
.07, p<.05) but was not significantly correlated with community 
disadvantage (r = -.04, p>.05). 
ADHD PRS was not associated with marijuana use disorders and the 
ADHD PRS × community disadvantage and ADHD PRS × parental 
monitoring interactions were also not significant, nor were 3-way 
interactions involving sex, ADHD PRS, and either community 
disadvantage or parental monitoring. 







disadvantage score was 
calculated using census-
tract level items from the 
1990 and 2000 Decennial 



























5 other pT 
 
ADHD traits were measured 
with The Autism-Tics, 
AD/HD and Other 
Comorbidities Inventory (A-
TAC)99 assessed by 
parents at ages 9 and 12 
years 
 
Covariates: sex, age, PCs 
ADHD PRS was associated with ADHD traits at ages 9 and 12 years 
(β [SE] = 0.27 [0.03], R2 = 8.4 x 10−3, p-value 5.9x10-19) and ADHD 
trait subscales hyperactivity/impulsivity (β [SE] = 0.14 [0.02], R2 = 7.7 
x 10−3, p-value 1.9x10-19) and inattention (β [SE] = 0.13 [0.02], R2 = 
6.0 x 10−3, p-value 2.9x10-15) 
After excluding children with ICD-10 diagnosed ADHD, ADHD PRS 
was still associated with ADHD traits (β [SE] = 0.21 [0.03], R2 = 6.2 x 
10−3, p-value 2.2 x 10-13) and the ADHD subscales.  























Structural MRIs; Image 
processing using 
FreeSurfer to extract 
cortical and subcortical 
brain volumes. Ten 
volumetric brain measures 
employed as outcomes: 
total brain volume (TBV), 
cortical gray matter (GM), 
ADHD PRS was associated with attention problems subscale (b . 
0.12, SE 0.00, p = 5.36 x 10-5). 
ADHD PRS was associated with smaller caudate volume (result for 
strongest prior: (b =-0.08, SE 0.03, puncorrected=7.49  10
4) across 
all priors except prior 1 at p<.05 and one prior was significant after 
FDR correction.  
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range: 8.72–










total white matter, 
subcortical GM, ventricular 
volume, cerebellum, 
amygdalahippocampus 
complex, caudate, putamen 
and thalamus (final 3 are 
subcortical brain volumes) 
Assessed on CBCL75 
attention problems subscale 
at ages 8-11 years 
Covariates: sex, age, total 
intracranial volume (for all 
except TBV analysis), PCs 
In subsequent mediation analyses, no evidence of caudate volume 
acting as a mediator between ADHD PRS and attention problems in 
full sample. Stratified by sex, mediation was significant for boys, 
indicating that 11% of the association between ADHD PRS (prior 
.0.01) and attention problems was mediated by differences in 
caudate volume. 
ADHD PRS was associated with smaller TBV (result for strongest 
prior: ß =-0.07, SE 0.03, puncorrected = .006) across all priors except 
prior 0.01 at p<.05, but none significant after FDR correction. 





















44.89, SD 9.73)  
13% female, 
87% male 
n = 587 Control 
subjects 
recruited from 
blood donors at 
PRS 
calculation 
based on six 
pT (0.001 - 
1)  
 
DSM-IV74 criteria for 
substance use disorder.  
Covariates: sex, age, PCs 
 
ADHD PRS was not associated with substance use disorders after 
multiple testing correction (Pseudo R2 ~0.4, .p<.05, p > 0.002)  
Results similar when MHC included.  






















119 cases, 339 
controls 
Mean age at 
first scan 11.47 
years, SD 3.54; 
mean age at 
second scan 
16.13 years, 












ADHD ascertained using 
clinician-administered 
Parent Diagnostic Interview 
for Children and 
Adolescents100. 
Longitudinal growth in 
volume across 2 time points 
modeled linearly for 4 brain 
divisions: cerebral cortex, 
basal ganglia, cerebellum, 
cerebral white matter, and 
one region of interest: the 
right lateral prefrontal 
cortex. 
Covariates: adjusted for 
age at baseline scan, 
interscan interval, sex and 
PCs 
ADHD PRS was not associated with any brain growth phenotypes (all 
P > 0.1).  























sample, USA  
European-only 
sample n = 514 
(337 ADHD, 
71% male; 177 
non-ADHD, 
52% male) age 
range: 7-11 
years 





















ADHD diagnoses made 
using DSM-IV criteria and a 
best estimate procedure. 
 
Separate parent and 
teacher-rated ADHD 
symptom latent variables 
derived from data on 3-4 
published ADHD measures 
that capture inattention and 
hyperactivity.  
 
Cognitive latent variables 
were captured using PCA 
models from data on 
laboratory measures of 




information processing, and 
processing speed.  
 
Covariates: sex, age, PCs 
ADHD PRS was associated with ADHD diagnosis (Nagelkerke R2 
=0.045%; b = 0.233, SE = 0.053, p = .000011) and both parent and 
teacher-rated ADHD symptom latent variables (R2 =0.033%; b = 
0.185, SE = 0.043 p = 1.69E-05 and R2 =0.027%; b = 0.165, SE = 
0.042, p = 8.55E-05 respectively).  
Of the five latent cognitive variables, ADHD PRS only predicted 
working memory (b = 0.227, SE = 0.040, p = 1.39E-08) and 
vigilance/arousal (b = 0.130, SE = 0.049, p = .0079). It did not predict 
slow output speed, mental clock or response inhibition. 
In mediation models, the ADHD PRS effect on ADHD diagnosis was 
statistically mediated by working memory (indirect effect, b = 0.101, 
SE = 0.029, p = .00049, 43% of genetic effect accounted for) and 
arousal/alertness (indirect effect b = 0.115, SE = 0.041, p = .005, 
49% of genetic effect accounted for). The same was found for 
models with ADHD PRS predicting parent and teacher-rated ADHD 
symptom latent variables, with 43-51% of the genetic effect 
accounted for by the latent cognitive variables.  
Direct PRS tests had a Hochberg correction p<.05. Mediation models 
used p<.05. 
Analyses repeated including non-European LONG sample 
participants, and changing the discovery sample to be European-









and Ireland.  
N = 480 ADHD 
cases aged 5-
18 years (mean 





N = 1208 
controls, age 7-
60 years (mean 










ADHD status using DSM-IV 
criteria determined with 
parental semi-structured 
interview and the Conners’ 
Parent Rating Scale107  
Covariates: gender, age2 , 
age x gender, PCs 
 
ADHD PRS explained 3.25% variance in ADHD case–control status 
(Nagelkerke’ s R2 =  0.03, p =  7.6E− 15)  


















based on 5 
pT (0.0005 
– 0.5) as 






9 participation phenotypes 
derived. Participation 
defined as responding to a 
questionnaire or attending a 
clinic for which the whole 




calculated by summing the 
number of questionnaires/ 
clinics completed and or 
clinics attended 
ADHD PRS was negatively associated with all 9 mother and children 
participation phenotypes. For example, ADHD PRS predicted mother 
total participation score negatively (ES = -2.18, 95% CI -2.71-1.64) 
and it predicted the child total participation score negatively (ES = -
2.14, 95% CI -2.63-1.64). 






























based on pT 
1 (using a 
prior) 
 
Parents reported on twins’ 
ADHD traits via the 
Strength and Difficulties 
Questionnaire71 
hyperactivity subscale and 
the Conners’ rating 
scales107 at ages 12 and/or 
16 years.  
Educational attainments 
based on standardized 
tests taken at the end of 
compulsory education in the 
United Kingdom (General 
Certificate of Secondary 
Education; GCSE) as 
obtained for twins at age 16 
years.  
BMI and height were self-
reported.  
IQ involved verbal and 
nonverbal ability using 
WISC-III assessments.  
Psychotic experiences 
assessed using the Specific 
Psychotic Experiences 
Questionnaire108 at age 16. 
The ADHD PRS effect was split into between family and within family 
effects using DZ twin data. 
The between family ADHD PRS effect, which is estimated 
independent of the within family effect, significantly predicted more 
ADHD traits (b = .11, CI .08-.14; p = 6.8 x 10-9), higher BMI (b = .07, 
CI .03-.11; p = .008), lower IQ (b = -.09, CI -.12--.05; p = 4.5 x 10-4) 
and lower GCSEs (b = -.18, CI -.21--.15; p = 7.3 x 10-17).   
The within family ADHD PRS effect showed that, within pairs, the 
twin with higher ADHD PRS had more ADHD traits than their co-twins 
(b = 0.12, CI .08-.17, p = 1.50e-7). Within pairs, the twin with higher 
ADHD PRS also lower GCSE grades than their co-twins (b = -0.06, 
CI -.10--.03 p = .001).  
The ADHD GPS within-family prediction was significantly lower than 
between-family prediction for GCSEs (b =-.12, CI -.16--.07, p = 4.95e-
5, Diff = 65.4%).  The between family ADHD PRS effect on GCSEs 
significantly reduced when socioeconomic status was controlled for 
(p = 7.69 x e-4) but was still significant.  
The ADHD PRS also significantly predicted lower SES (b =-.17, CI -
.21--.13, p = 1.32e-13) 
The ADHD PRS did not significantly predict (either as within or 
between family effect): height, self-rated health, neuroticism, 
psychotic experiences.  
Results were stable when analyses were rerun on the sample split by 
same-sex/opposite-sex twins, based on differences in chip, using a 
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Neuroticism assessed using 
a Big Five questionnaire 109. 
Self rated health assessed 
using the RAND Short-Form 
Health Survey110. 
Socio Economic Status: 
based on maternal age at 
birth of the first child, 
maternal and paternal 
highest education level, and 
maternal and paternal 
occupation. 
Covariates: PCs, chip, 
plate, and phenotypes were 
corrected for age and sex 
 
prior pT of 0.1, and using PRS’s with British samples removed, and 
results 
Statistical significance was p<.01, based on an Benjamini Hochberg 
false discovery rate (FDR) adjustment 
OTHER 33. 
Schoele











age 8, 10 and 





based on 99 
pT (0.01 – 
1)  
 
Exposure to bullying was 
assessed based on child 
reports at 8, 10, and 13 
years of age using a 
modified version of the 
Bullying and Friendship 
Interview Schedule 
(BFIS)111. Mean score of 
exposure to bullying across 
ages was used.  
 
Covariates: Sex, PCs 
ADHD PRS was significantly associated with bullying (standardized 
b, 0.085; 95% CI, 0.056-0.113, P<.001). In a multi-PRS analysis with 
10 other significant PRS predictors, ADHD PRS was still significantly 
associated with bullying (standardized b, 0.062; 95% CI, 0.032-0.092, 
p<.001). 
Repeated multi-PRS analysis which looked at chronicity of bullying 
showed similar results. There was no evidence of an interaction 
effect of sex.  The multi-PRS association of ADHD PRS and bullying 
was no longer significant when bullying perpetration was included in 
as a covariate.  
Permutation and false discovery rate–corrected p values were 
















302 with ADHD 
(72.5% male), 
mean age 9.9 














based on pT 
0.5 
 
Diagnosis based on: 
diagnostic parent interview 
(Kiddie Schedule for 




[KSAD-S-E]), parent and 
teacher standardized rating 
forms that assessed 
symptoms and impairment, 
clinician observations 
 
A total of 568,281 probes 
assessed for DNA 




methylation across all 
probes), as well as 
differentially methylated 
positions (DMPs) derived 
from saliva. 
Cell-type adjusted beta 
values were the outcome 
variables 
 
Covariates: sex, age, PCs, 
medication usage, maternal 
smoking, number of missing 
The ADHD PRS was associated with reduced DNA methylation at 
one probe, cg15472673 at genome-wide significance (p = 6.71E–8) 
and this association remained (p = 9.76e–8) when including ADHD 
status in the regression model, suggesting that the effect was not 
driven by elevated polygenic burden in ADHD cases. The probe is 
located between the GART and SON genes in a CpG island of a 
bivariate promoter. The SNPs in the ADHD PRS are not direct 
methylation quantitative trait loci for cg15472673, as such the 
association with the PRS is not thought to be a genetic effect on DNA 
methylation. The ADHD PRS was associated with DNA methylation 
levels at 12 other probes at p < 1.0e–5. 
No sex interactions were significant at the EWAS significance 
threshold. 
In terms of differentially methylated regions, one region on 
chromosome 6 within the major histocompatibility complex was 
identified, in which the ADHD PRS associated with 8 probes 
associated with the  
ADHD PRS. The association was sex-specific: in females a higher 
PRS was associated with higher methylation levels, and the opposite 
was found for males.  
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SNPs in the PRS 
calculation for each patient 































based on 7 
pT (0.01 – 
0.5)  
 
Inattention and hyperactivity 
disorder symptoms 
measured using clinician 
administered Diagnostic 
Interview for Children and 
Adolescents for parents 2. 
Adult symptoms of ADHD 
were measured by 
clinicians using the 
Conners’ Adult ADHD 
Diagnostic Interview for 
DSM-IV 3.  
Neuroanatomic imaging, 
and imaging of white matter 
tract microstructure 
Other disorders in adults 
were ascertained through 
the Structured Clinical 
Interview for DSM-IV-TR 
Axis I Disorders 4.   
Working memory spans 
assessed through number 
of correctly recalled 
digits/tapping patterns.  
Processing speed assessed 
using visual matching task 
(from the Woodcock 
ADHD PRS predicted symptoms of hyperactivity–impulsivity (b =0.11 
SE = 0.046, p=.02, at FDR q  < 0.05), but not inattention (at FDR q  < 
0.05).  
Of the neuroanatomic mediators (White matter microstructure and 
cortical anatomy), the following emerged as partial or complete 
mediators: axial diffusivity within regions of the right anterior (29% of 
the genetic effect) and right superior corona radiate (21% of the 
genetic effect); For thickness, a region within the left dorsomedial 
prefrontal cortex (24% of the genetic effect); For surface area, a 
region within the right lateral temporal cortex (22% of the genetic 
effect). 
Of the 6 cognitive domains, 3 emerged as significant mediators of 
ADHD PRS Æ hyperactivity–impulsivity symptoms: working memory 
(28% of the genetic effect), IQ (20% of the genetic effect) and 
focused attention (17% of the genetic effect). These mediators fully 
explained the association between ADHD PRS and hyperactivity–
impulsivity symptom.  Sustained attention, processing speed and 
perseverative/impulsive responding were not significant mediators. 
In serial mediation analyses (polygenic risk → brain regions → 
cognition → symptoms); two potential pathways emerged.   
For mediation analyses of neuroimaging data, used permutation and 
voxel-wise p<.05 
Results mostly held when analyses repeated combining the two 
largest subpopulations; with medication as a covariate, excluding 
those with comorbid disorders and confining analyses to one member 
of each family 
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Johnson III Test of 
Cognitive Abilities113).  
IQ was assessed using an 
age appropriate version of 
the Wechsler scales104 .  
Attentional processes 
measured using the 
Conners’ Continuous 
Performance Test114, from 
which focused attention, 
perseverative/impulsive 
responding and sustained 
attention were derived. 
Covariates: Age, sex. Also 
for imaging data: motion 
and quality control scores 
Applied a false discovery rate and indicate the results that survived at 
















in infancy (9-20 
weeks) and at 





based on six 
pT (0.01 - 1)  
 
Neuromotor functioning 
assessed during in person 




versions used for 9-15 
week olds and 16-20 week 
olds. Overall scale and 
Senses, Responses, 
Hypertone, Hypotone, Tone 
subscales. Tone included 
both active and passive 
muscle strength.  
 
Parent-rated autistic traits 
at age 6 years using the 
Social Responsiveness 
Scale 
The ADHD PRS did not predict neuromotor functioning total or 
subscales after Bonferroni correction; it predicted “Senses and other” 
subscale nominally (b=0.43, CIs .001-.06; p=.04, R2 =0.01%). 
ADHD PRS did not predict autistic traits in whole sample. ADHD PRS 
predicted autistic traits in boys only (pT<.10; b=.176, CIs .09-.27, 
p=<.001) after correction for multiple testing but not girls. 
Models that were adjusted for the autism or schizophrenia PRS did 
not change results.  
























baseline at age 
14 years and at 
follow up at 16 
years  
49% female; 






pT <.50  
 
 
Parent-rated Strengths and 
Difficulties Questionnaire 
hyperactivity-inattention 
subscale71  ages 14 and 16 
years. 
Neuropsychological 
variables: Working memory 




through a self-ordered 
searching task at age 14.  
Delay discounting assessed 
using the Monetary Choice 
Questionnaire117 which 
includes items pitting a 
smaller intermediate reward 
against a larger delayed 
reward at age 14.  
Intrasubject variability was 
the standard deviation of 
reaction time in successful 
go tasks in the stop signal 
functional MRI task118.  
Covariates: age, sex, and 
site. Analyses on GMV also 
ADHD PRS was associated with higher ADHD total trait score at age 
14 (r=.14, df=1779, p<.001, 95% CI .097-.188), working memory 
errors (r=0.07, df=1779, p=0.002, 95% CI=0.026, 0.121) and delay 
discounting rate (r=0.06, df=1779, p=0.007, 95% CI=0.021, 0.109).   
For lower gray matter volume, the ADHD PRS associated only with 
the posterior occipital cluster (r=-0.06, df=1777, p=0.009, 95% CI=-
0.106, -0.015).  
Nonsignificant associations are not described in publication. 




controlled for handedness 























Age range 7-13 
years, m=10.38 










based on pT 





ADHD diagnoses were 
best estimate research 







traits using a latent 
variable derived from five 
commonly used scales. 
Teacher-reported ADHD 
traits using a latent 
variable derived from 
three commonly used 
scales. 
Working memory 
assessed using digit 
span backward, spatial 
span backward, and N-
back task. 
MRI-based resting 
functional connectivity in 
a targeted set of 
subcortical structures. In 
total, 6 circuits involving 
PRS statistically predicted ADHD diagnosis (b = .153 [.073 SE], p = 
.038) and parent-reported symptoms (b = .138 [.059], p = .020) but 
not teacher-rated symptoms. ADHD PRS did predict working memory 
(b = 2.194 [.060], p = .001) 
ADHD PRS associated significantly with connectivity between the left 
caudate nucleus and a cluster within the intraparietal sulcus (b = .467 
[.152 SE], p = .002), also reported as a significant correlation (r = 
.026, .162 SD) and significantly associated with a cluster of regions in 
the right nucleus accumbens with connectivity to cortex (b = .270 
[.117 SE], p = .021). 
No significant associations of the ADHD PRS with: connectivity of the 
right caudate nucleus; with connectivity between brain regions and 
either the left or the right amygdala; or with the connectivity of 
different clusters correlated to the left nucleus accumbens. 
A mediation model showed that the PRS-ADHD diagnosis 
association was suppressed by 60% when the connectivity of a 
circuit (the connectivity between the left caudate nucleus and the 
right parietal cortex) was included in the model.  Effect sizes were 
similar for both sexes. No other mediation models showed a 
significant impact of any of the other connectivity circuits on the 
ADHD PRS-ADHD diagnosis, ADHD PRS-ADHD symptoms or 
ADHD PRS-working memory associations. 
Results reported as similar when current or previous medication use 
included in the models, when the sample was sex-matched and with 
other PRS pT. 
Permutation testing was applied. 
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subcortical regions: left 
and right caudate, left 
and right nucleus 
accumbens, left and right 
amygdala. 





















and 2nd degree 
relatives of all 
ages up to 4 
generations.  
Age range 7-13 
years, m=10.38 










Diagnoses of ASD, ASD or 
combined ASD and ADHD, 
based on ICD-10 
Affected status contingent 
on PRS score 
PRS score had Danish 
samples removed.  
Covariates: sex, age 
The ADHD PRS significantly predicted ASD, ADHD and combined 
ASD and ADHD. No further information provided. 
A significant association was found between the ADHD PRS and 
being a patient, an affected relatives and unaffected relatives (p = 






























PRS analyses  




individuals (n = 
5599 cases; n = 
12699 controls) 
n = 37,076 
biologically 
independent 
10 pT were 
employed 
(from 5 X 
10-8-1). 
 





















PRS prediction considered 
a) within iPSYCh b) within 
PGC c) across all using 
leave-one-out analysis. 
iPSYCH cases diagnosed 
by psychiatrists at in- or out-
patient clinics mostly with 
ICD-10 identified using a 
Danish Psychiatric Register.  
Controls randomly selected 
from iPSYCH without ADHD 
or moderate/severe mental 
retardation.  
Individuals with a diagnosis 
of moderate to severe 
mental retardation were 
excluded from both cases 
and controls. 
Diagnoses of ADHD 
derived from range of 
published instruments in 
PGC samples.  
Covariates: Batch effects, 
genotyping wave and PCs 
ADHD PRS predicted ADHD across all target samples compared to 
controls or pseudocontrols.  
Within iPSYCH (using five-fold cross-validation), mean of maximum 
variance explained by ADHD PRS using estimated PRS 
Nagelkerke’s R2 was 5.5% (SE = 0.0012), range .047-.06. Within 
iPSYCH, OR = 1.56, 95% confidence interval (CI): 1.53–1.60.   
Within PGC (with iPSYCH as discovery sample), OR = 1.26 (1.22-
1.31) variance explained on liability scale .0103, p = 2.4 E-35) 
Across PGC and iPSYCH waves, average variance explained on 
liability scale = .0371 (se = .0029)  
Increasing deciles of ADHD PRS associated with increasing OR for 




individuals (n = 

















n = 135,726, 
age 40-73 
years (M = 
























multiple pT  
between 0 
and 0.5 at 
increments 
of .001 
BMI using height and 
weight 
General cognitive ability 
obtained by 2-minute 
verbal-numerical reasoning 
test 




Anxiety and depressive 
disorders, bipolar disorder 
and schizophrenia identified 
either through self-report or 
ICD-10 codes. 
Alcohol intake frequency 
(via self report question); 
alcohol-related diagnosis 
through either self-report or 
ICD-10 codes.  
Smoking accessed through 
hospital records 
Risk taking coded 
dichotomously based on 
ADHD PRS significantly positively predicted BMI (R2 = .45%; p = 4.5 
x 10-129), cognitive ability (R2 = .38%; p = 4.5 x 10-36), alcohol 
intake frequency (R2 = .09%; p = 8.1 x 10-29), alcohol dependency 
(R2 = .21%; p = 4.5 x 10-6), tobacco use (R2 = .33%; p = 4.2 x 10-
21), risk taking (R2 = .12%; p = 9.3 x 10-25), neuroticism (R2 = .09%; 
p = 2.2 x 10-24), depressive disorder (R2 = .11%; p = 2.2 x 10-13), 
height (R2 = .03%; p = 8.7 x 10-20). 
ADHD PRS did not significantly predict anxiety disorder, bipolar 
disorder or schizophrenia.  
Within neuroticism, the items were also studied. ADHD PRS 
significantly predicted mood swings (R2 = .002%), fed-up feelings (R2 
=.20%), feelings of loneliness and isolation (R2 = .19%), 
miserableness (R2 = .13%), irritability (R2 = .09%), being tense/highly 
strung (R2 = .07%), guilty feelings (R2 = .05%), and having easily hurt 
feelings (R2 = .05%). It did not predict being a nervous person or a 
worrier, suffering from nerves or often worrying after embarrassment. 
Secondary analyses showed there were not significant sex x PRS 
interaction effects. 
Of 8 control phenotypes, included to check for specificity, ADHD PRS 
significantly and negatively predicted height (R2 = .03%) and age (R2 
= .03%), but not the other 6 control phenotypes. 
Significance threshold of p < 4.5 x 10-4 applied. 
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yes/no answer to “Would 
you describe yourself as 
someone who takes risks?”  
 
Covariates: birthplace, age, 








The Child and 
Adolescent 







diagnoses n = 
217-443; 





diagnoses n = 
296- 1226; 
















4 other pT 
ADHD, any anxiety 
disorder, any depression 
disorder or any anxiety or 
depressive disorder. 
CATSS had both registry-
based ICD-10 clinical 
diagnoses (captured from 
ages 9-22yrs) and 
screening-based diagnoses 
based on parent-/self-rated 
items from the Autism-Tics, 
ADHD and Other 
Comorbidities inventory 
(ATAC) (assessed at ages 
9 or 12 years)99.  
 
ALSPAC had algorithm-
based diagnoses based on 
a semistructured interview, 
the Development 
and Well-Being 
Assessment (DAWBA70 at 
ages 7,10,13 and 15 years 
from parents. Self ratings 
were also obtained for 
anxiety and depression at 
15 and 18 years. 
The ADHD PRS consistently predicted ADHD diagnoses using 
registry clinical diagnoses (OR = 1.39 (1.26–1.54) p =7.2E-11), 
screening research diagnoses (OR = 1.25 (1.17–1.34) p =2.8E-11) 
and algorithm-based research diagnoses (OR = 1.76 (1.51–2.05) p = 
4.9E-13).  
The ADHD PRS predicted anxiety disorders using registry clinical 
diagnoses (OR = 1.16 (1.02–1.32) p = .020), and algorithm-based 
research diagnoses (OR = 1.20 (1.08–1.33) p =.00046) but not 
screening research diagnoses.  
The ADHD PRS predicted depressive disorders only using algorithm-
based research diagnoses (OR = 1.19 (1.06–1.33) p =.0027) and not 
using registry clinical or screening research diagnoses.  
The ADHD PRS consistently predicted any anxiety or depressive 
disorder using registry clinical diagnoses (OR = 1.16 (1.04–1.29) p = 
.0062), screening research diagnoses (OR = 1.12 (1.01–1.25) p = 
.031) and algorithm-based research diagnoses (OR = 1.17 (1.07–
1.27) p = .00063).  
Repeated analyses using other pT showed similar results.  





diagnosed n = 
199-724; 










Covariates: age, PCs 
 



















10 and 18 
years  
 






pT<.50   
 
Self-report depressive 
symptoms using the short 
Mood and Feelings 
Questionnaire120 6 ages 
(10.5, 12.5, 13.5, 16.5, 
17.5, 18.5 years).  
 
Categorized individuals 
scoring above/below clinical 
cut-off of scale. 
 
Family history measured as 
the number of family 
members with a history of 
depression or 
schizophrenia weighted by 
relatedness (first or second-
degree relative) 
 
Three trajectory classes 
identified: persistently low 
(73.7%), later-adolescence 
onset (17.3%), and early-
adolescence onset (9.0%). 
 
The AHDH PRS did not correlate significantly with family history for 
major depression or schizophrenia (both p>.05).  
 
ADHD PRS predicted the early-adolescence–onset depression class 
(OR, 1.32; 95%CI, 1.13-1.54; P < .001)  
In multi-PRS analyses including also the schizophrenia and MDD 
PRS, the ADHD PRS still predicted the early (OR = 1.27 95% CI 
1.08-1.50, p=.003) 
 
ADHD PRS did not predict the later-onset depression trajectory class 
in either the univariate analysis or the multi-PRS analysis.  
 
Analyses that were rerun including PCS, adjusting for missing 
phenotypic data, and adjusting for missing genetic data, showed 
similar findings.  
 




























(mean = 13.5, 
























Total adversity score 
calculated as mean of 10 
binary indicators: (1) 
biological mother’s 
education, (2) biological 
father’s education, (3) 
homeownership status, (4) 
annual household income, 
(5) emotional abuse, (6) 
physical abuse, (7) sexual 
abuse, (8) neglect, (9) 
exposure to violence at 
home (10) bullying. Socio-
economic and victimization 




Under 18 years: Kiddie 
Schedule for Affective 
Disorders and 
Schizophrenia (KSADS)– 
Present and Lifetime 
Version 
Over 18 years: Structured 
Clinical Interview for DSM-5 
 
Externalizing symptoms 
score from KSADS 
interview 
 
ADHD PRS was associated with ADHD symptoms (ß = 0.21, 95% CI 
0.10 to 0.32, p < 0.001, R2 = 3.0%) and externalising behaviors (ß = 
0.23, 95% CI 0.12 to 0.34, p < 0.0001; R2 = 4.0%; r= .22, p<.05).  
 
ADHD PRS was associated with adversity (b = 0.23, 95% CI 0.13 to 
0.34, p < .0001. R2= 4.0%) as well as the socio-economic 
adversity (b = 0.10, 95% CI 0.01 to 0.20, p = .028; R2= 2.0%) and 
victimization adversity subscales (b = 0.24, 95% CI 0.12 to 0.35, p < 
.0001 R2= 3.3%). 
 
ADHD PRS did not significantly associate with IQ or with family 
history for schizophrenia. 
 
Mediation models to test the ADHD PRSÆadversity association 
showed that externalizing symptoms mediated 22% of the total effect 
of ADHD PGS on adversity. IQ did not mediate the ADHD 
PRSÆadversity association.  
 
Associations held when run separately in individuals with and without 
ADHD; on the subset of participants under age 17; after excluding 
offspring of control parents; among the subset of participants who 
have a biological parent with mental illness and on the subset with 
self-reported European descent. 
 
Univariate PRS analyses employed p < 0.003 (Bonferroni 




IQ assessed with Wechsler 
Abbreviated Scale of 
Intelligence – Second 
Edition121 or Wechsler 
Preschool and Primary 
Scale of Intelligence. 
 
Covariates: age, sex, time 
in the study, PCs 
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Note. Sample n are given for genotyped PRS sample used in analyses. PCs, principal components to control for population stratification. pT, single nucleotide 
polymorphism p-value threshold for PRS. If authors did not select a primary pT, results reported for most significant pT. 
 
Outcome categories: ADHD*, attention deficit hyperactivity disorder diagnosis; ADHDt, ADHD traits; ADDICTION, substance and non-substance-based 
addiction phenotypes ASD, autism diagnosis; ASDt, autistic traits, BIOLOGICAL, genetic or methylation phenotypes including other PRS; BRAIN, imaging-
based assessments of brain variables including structure, function and connectivity; EA, educational attainment phenotypes; EXTERNALISING, externalizing 
behaviors; MH, mental health phenotypes; NEUROPSYCH, neuropsychological phenotypes; PHYSICAL, physical health phenotypes; OTHER, uncategorized 
phenotypes.  
 
AHPVT: Add Health Picture Vocabulary Test 
BFIS: The Bullying and Friendship Interview Schedule 
BRIEF: The Behavior Rating Inventory of Executive Function  
CBCL: Child Behavior Check- list/6–18  
CES-D: The Center for Epidemiologic Studies Depression Scale  
DAWBA: The Development and Well-Being Assessment  
EDI-2: The Eating Disorder Inventory-2 
ICD: International Statistical Classification of Diseases and Related Health Problems  
PCA: Principal Component Analysis 
PT: p-value threshold of discovery GWAS as used for ADHD PRS 
SCDC: The Social and Communication Disorders Checklist 
SDQ: The Strengths and Difficulties Questionnaire  
SWAN: Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Rating Scale  




Criteria list for the quality assessment of studies on the association between the ADHD 
PRS and outcomes measures 
Criteria     
 
1. Study participation; Study sample adequately represents the population of interest  
(A)  Description of the key characteristics of the study population (distribution by age, 
gender and ancestry/ethnicity)               
(B) The sampling frame and recruitment are described, including characteristics of the 
place of recruitment or authors clearly reference where this information can be 
found 
(C) Inclusion and exclusion criteria are described or authors clearly reference where 
this information can be found 
(D) Information about participation at baseline and potential attrition (for genetic 
data) are described or authors clearly reference where this information can be 
found 
  
2. Predictor measurement; ADHD PRS is adequately measured 
(E) Description of genetic data collection (e.g., blood, saliva) and genotyping (array) 
is provided, and target sample was not part of GWAS 
(F) Genetic data were subject to adequate quality control (minor allele frequency, 
missing rate, relatedness participants, sex mismatch, and genotype quality), an up 
to date imputation method and an established reference panel was used 
(G)  The ADHD PRS is adequately calculated (e.g., pruning/clumping of SNPs) 
  
3. Outcome measurement; Outcome of interest is measured in a similar way for all 
participants 
(H) A clear definition of the outcome measures is provided 
(I) Several indications are provided for the validity and reliability of the outcome 
measure, or a reference is provided. 
(J) The method and setting of outcome measurement is the same for all study 
participants 
 
4. Confounding measurement; Important potential confounders are appropriately 
accounted for 
(K) Age, gender and Socio Economic Status are accounted for in the analysis 
(L) Population stratification and potential batch effects are accounted for in the 
analysis 
(M) In case of clinical samples, treatment and comorbidity are accounted for in the 
analyses 
 
5. Analysis and data presentation; Statistical analysis is appropriate 
(N)  Sufficient presentation of the data to assess the adequacy of the analytic strategy  
Table
(O)  The number of participants in the target sample supports sufficient statistical 
power (N > 400) 
(P) The selected statistical model is adequate for the design of the study 
(Q) There is not evidence of selective reporting of results, and proper correction for 
multiple testing was applied. 
Table 3: 
 





Note: (≥ 75%): within a category, at least 75% of the findings of studies had to agree on 





evidence   
 
Strong Consistent findings (≥ 75%) in at least two high quality studies 
Moderate Consistent findings (≥ 75%) in one high quality study and at least one study 
of lower quality 
Weak Findings in one high quality study or consistent findings (≥ 75%) in at least 
3 or more studies of lower quality 
Inconclusive Inconsistent findings irrespective of study quality, or less than 3 lower 
quality studies available 
Table
Table 4: Quality assessment results 
 
    1) Study sample   2) ADHD PRS  3) Outcomes  4) Confounders  5) Analysis, data presentation N 
    A B C D E F G H I J K L M N O P Q bias 
 
Stojanovski et al. 2019  + + + + + + + + - + + + + + - + + 0 
 
Albaugh et al. 2019  + + + + -/+ + + + -/+ + + + NA + + + + 0 
 
Burton et al. 2019  + + + + + + + + + + -/+ + - + + + + 0 
 
Jansen et al. 2019  + + -/+ + + + + + + + -/+ + -/+ + + + + 0 
 
Li 2019a    + + + + + + + + - + + + NA + + + + 0 
 
Gialluisi et al. 2019  + - + - + + -/+ + - - - -+ - + + + + 2 
 
Rietveld & Patel 2019  + - -/+ - - - - + -/+ -/+ + + NA + + + + 2 
 
Piasecki et al. 2019  + + + + + + + + - + -/+ + NA + + + -/+ 0 
 
Torske et al. 2019  + + + + + + + + -/+ + -/+ + - + - -/+ - 1 
 
Nigg et al. 2019   + + + + + + + + - + -/+ + + + -/+ + -/+ 0 
 
Dickinson et al. 2019  + + + - + + + + + + -/+ + - + -/+ + -/+ 0 
 
Cabana-Domínguez et al. 2019  + + + + + + + + + -/+ - + - -/+ + + -/+ 0 
 
Ohi et al. 2020   + + + + + + + + + + - + - + - + -/+ 0 
 
Mooney et al. 2020a  + -/+ + + + -/+ + + + + -/+ + -/+ + - + + 0 
 
Vuijk et al. 2019   + -+ + + + + + + + + -/+ + + + - + + 0 
 
Li 2019b    + + + + + + + + + + + + NA + + + -/+ 0 
 
Riglin et al. 2019   + + + + + + + + + + + - NA + + + -/+ 0 
 
Grigoroiu-Serbanescu et al. 2019 + -/+ -/+ - -/+ -/+ + + + -/+ - - - -/+ + -/+ + 1 
 
Wimberley et al. 2019  + + + + + + + + + + + + -/+ + + + + 0 
Table
 
1    2   3   4   5 
    A B C D E F G H I J K L M N O P Q #   
 
Riglin et al. 2020   + + -/+ + + + + + + + - - NA + + + -/+ 1 
 
Barker et al. 2019  + + -/+ + -/+ + + + + + -/+ + NA + + + + 0 
 
De Zeeuw et al. 2019  -/+ + + + + + + + + + -/+ + NA + + + + 0 
 
Yao et al. 2019   + + + + + + + + + + -/+ + - + + + -/+ 0 
 
Rabinowitz et al. 2018  + + -/+ + + + + + + -/+ -/+ + - + + + + 0 
 
Taylor et al. 2019  + + + + + + + + + + -/+ + NA + + + + 0 
 
Alemany et al. 2019  + + + + + + + + + + -/+ + NA + + + + 0 
 
Gurriarán et al. 2018  + + + + + + + + + -/+ -/+ + - + + + + 0 
Szekely et al. 2018  + -/+ -/+ + + + + + + - -/+ + NA -/+ + + + 0 
Nigg et al. 2018   + + + + + + + + + + -/+ -/+ + + + + + 0 
Hawi et al. 2018   + - + + + + + + + + -/+ + - + - + + 0 
Taylor et al. 2018  + + + + + + + + - + -/+ + NA + + + -/+ 0 
Selzam et al. 2019  + + + + + + + + -/+ + + + NA + + + + 0 
Schoeler et al. 2019  + + + + + + + + - + -/+ + NA + + + + 0 
Mooney et al. 2020b  + -/+ + -/+ + + + + + + -/+ + -/+ + -/+ + + 0 
Sudre et al. 2018   - - + - + -/+ + + + + -/+ -/+ + + -/+ + + 1 
Hermosillo et al. 2020  + + -/+ + + + + + + + -/+ + -/+ + -/+ + + 0 
LaBianca et al. 2020  - + - + - - + + + + -/+ - - -/+ -/+ + + 2 
 
1    2   3   4   5 
    A B C D E F G H I J K L M N O P Q #  
Serdarevic et al. 2020  -/+ + + + + + + + + + + + NA + + + + 0 
Shen et al. 2020   + + + + -/+ + + + -/+ - -/+ - -/+ + + + -/+ 1 
Demontis et L. 2019  + + -/+ -/+ + + + + + - - + - + + + + 0 
Du Rietz et al. 2018  + + + + + + + + -/+ + -/+ + NA + + + + 0 
Martin et al. 2018  + + + + + + + + + - -/+ + NA + + + -/+ 0 
Rice et al.  2019   + + + + + + + + + + -/+ + NA + + + -/+ 0 
Zwicker et al. 2019  + + + + + + + + -/+ + -/+ + NA + -/+ + + 0 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For more information, visit www.prisma-statement.org. 
 
Figure 1: PRISMA Flow Diagram 
 
Records identified through 
databases (Pubmed, PsycInfo, 
Embase) searching in February 
























Additional records identified in 
June and bibliographies checked   
(n = 49) 
Records after duplicates removed 
(n =151) 
Records screened 
(n = 151) 
Records excluded 
(n =94) 
Full-text articles assessed 
for eligibility 
(n = 57) 
Full-text articles excluded, 
with reasons 
(n = 13) 
Studies included in 
qualitative synthesis 
(n = 44 ) 























Supplemental Materials (Online Only)
 1 
Category (N studies) Measured traits (study number in Table 1) 
ADHD diagnosis (10) x Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) (3#, 18#, 29#, 
30#) 
x Retrospectively self-reported ADHD symptoms keyed to the DSM-IV (4) 
x ICD-10 (15#, 39#, 40#, 42) 
x Retrospectively Wender Utah Rating Scale (WURS), Kiddie-SADS clinical interview. Assessment 
of childhood ADHD was made by clinicians (18#) 
x Conners’ Parent Rating Scale (30#) 
x Best estimate research diagnoses from parent semi-structured clinical interviews, clinical 
observation and parent/teacher rating scales (38#) 
x Autism-Tics, ADHD and Other Comorbidities inventory (ATAC) (42) 
x Development and Well-Being Assessment (DAWBA) (42) 
ADHD traits (16) x Composite score of the Development and Well-Being Assessment (DAWBA) and the Strengths 
and Difficulties Questionnaire (SDQ) (1) 
x Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM5) (2) 
x Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Rating Scale (SWAN) 
score: Total, inattentive and hyperactive/impulsive subscales (5)    
x Dimensional score on an ADHD latent variable captured from hyperactivity and inattention 
subscales of four published ADHD scales (10#)  
x DSM-IV Axis 1 diagnoses; a range of parent-rated dimensional published scales of 
psychopathology (15#) 
x DSM-IV items retrospectively (16) 
x Wender Utah Rating Scale (WURS) and items from the Kiddie-SADS clinical interview (18#) 
x Child Behavior Checklist (CBCL) Attention Problem scales (22, 26) 
x Teacher Report Form (TRF) Attention Problem scales (22)  
x The Autism-Tics, AD/HD and Other Comorbidities Inventory (A-TAC) (25) 
x Separate parent and teacher-rated ADHD symptom latent variables derived from data on 3-4 
published ADHD measures that capture inattention and hyperactivity (29#) 
x SDQ (32) 
Supplementary Table 1: Measured traits for each category 
Supplemental Materials (Online Only)
 2 
x Conners’ Parent Rating Scale (32) 
x Inattention and hyperactivity disorder symptoms by clinician administered Diagnostic 
Interview for Children and Adolescents for parents (35#) 
x Strengths and Difficulties Questionnaire (SDQ) (37) 
x Parent-reported ADHD traits using a latent variable derived from five commonly used scales 
(38#) 
x Teacher-reported ADHD traits using a latent variable derived from three commonly used 
scales (38#) 
x ADHD symptoms: under 18 yrs: Kiddie Schedule for Affective Disorders and Schizophrenia 
(KSADS)– Present and Lifetime Version; over 18 yrs: Structured Clinical Interview for DSM-5 
(44) 
Addiction (8) x Lifetime DSM-IV criteria for alcohol abuse or dependence were assessed as the presence of at 
least 1 of the 4 items pertaining to alcohol abuse, and/or 3 of the 7 items pertaining to 
alcohol dependence occurring together in 12-month period (4) 
x Gambling: answering yes or no to “Have you ever bought lottery tickets, played video games 
or slot machines for money, bet on horses or sporting events, or taken part in any other kinds 
of gambling for money?”; and (if yes to the previous question), answer of yes or not to: “Has 
your gambling ever caused serious financial problems or problems in your relationships with 
any of your family members or friends?” (8) 
x Cocaine dependence DSM-IV (12#) 
x Presence of substance use disorder history (15#) 
x Addiction categorized first by alcohol, cannabis, and other illicit drugs and second categorized 
into severity into use, abuse and addiction (nicotine use not included) (19) 
x Composite International Diagnostic Interview-University of Michigan Version (CIDI-UM), 
National Survey on Drug Use and Health (NSDUH) (24) 
x Substance use disorder DSM-IV (27#) 
x Alcohol addiction ICD-10 (41) 
x Smoking through hospital records (41) 
Autism/autistic traits (5) x DSM-IV ASD diagnosis (3#) 
 3 
x Social Responsiveness Scale (9#, 15#, 36) 
x ICD-19 (39#) 
Brain measures (8) x Neuroanatomic imaging, and imaging of white matter tract microstructure (1) 
x Total brain volume (TBV) and subcortical structures (14#) 
x Voxel-based morphometry measures of whole-brain grey matter (21) 
x Neural responses to reward anticipation and reward outcome from activation maps from a 
Monetary Incentive Delay fMRI task (21) 
x Total brain volume (TBV), cortical gray matter (GM), total white matter, subcortical GM, 
ventricular volume, cerebellum, amygdalahippocampus complex, caudate, putamen and 
thalamus (26) 
x Longitudinal growth in volume across 2 time points modeled linearly for 4 brain divisions: 
cerebral cortex, basal ganglia, cerebellum, cerebral white matter, and one region of interest: 
the right lateral prefrontal cortex (28#) 
x Neuroanatomic imaging, and imaging of white matter tract microstructure (35) 
x Stop signal functional MRI task (37) 
x MRI-based resting functional connectivity in left and right caudate, left and right nucleus 
accumbens, left and right amygdala (38#) 
Educational attainment (9) x Cognitive ability, measured by Add Health Picture Vocabulary Test (AHPVT) (4) 
x Educational attainment, measured by the question ‘what is the highest level of education that 
you have achieved to date? (4, 22) 
x Eight outcomes relating to word reading, spelling, rapid naming, and phonology that are 
considered core deficits in dyslexia: Word reading (WRead), nonword reading (NWRead), and 
word spelling (WSpell), Phoneme awareness (PA), digit span (DigSpan, a measure of verbal 
short-term memory), and rapid automatized naming of letters (RANlet), digits (RANdig), and 
pictures (RANpic) (6) 
x Wide-Range Achievement Test [WRAT] reading subtest and Wechsler Adult Intelligence Scale 
[WAIS] used for cognitive assessments (11#) 
x Wechsler Intelligence Scale for Children–Fourth Edition and the Wechsler Adult Intelligence 
Scale–4th Edition (15#, 35#) 
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x Word Reading and Numerical Operations of the Wechsler Individual Achievement Test–Third 
Edition (WIAT III) (15#) 
x Whether education was completed by age 23 years or not (15#) 
x Cito score, a Dutch nationwide standardized educational achievement test (22) 
x Wechsler Intelligence Scale III, verbal and nonverbal ability (32) 
x UK General Certificate of Secondary Education; GCSE (32) 
x General cognitive ability obtained by 2-minute verbal-numerical reasoning test (41) 
x IQ assessed with Wechsler Abbreviated Scale of Intelligence – Second Edition or Wechsler 
Preschool and Primary Scale of Intelligence (44) 
Externalizing behaviors (8) x Irritability captured with latent variable based on two subscale scores: anger and modified 
soothability from the Temperament in Middle Childhood Questionnaire (TMCQ, and an 
oppositional defiant disorder irritable total score. Latent variables were also created for 
surgency-approach and sadness-anxiety (10#) 
x DSM-IV Axis 1 diagnoses; a range of parent-rated dimensional published scales of 
psychopathology (15#) 
x Aggressive behaviors, non-aggressive rule breaking and substance use behaviors assessed by 
in-person interviews (16) 
x Parent-reported data on Development and Well-Being Assessment (DAWBA)1—a structured 
research diagnostic interview—at ages 7, 10, 13 and 15 years (17) 
x Comorbid oppositional defiant disorder/conduct disorder (ODD/CD) (19#) 
x Impulsivity symptoms at age 19 assessed using self-reported Barratt Impulsivity Scale (BIS) 
(21) 
x Risk taking coded dichotomously based on yes/no answer to “Would you describe yourself as 
someone who takes risks?” (41) 
x Externalizing symptoms score from KSADS interview (44) 
Mental health (11) x Diagnoses based on the DSM-IV, the Center for Epidemiologic Studies Depression (CES-D) 
Scale, and an abbreviated 4-item version of the Cohen’s Perceived Stress Scale (4) 
x Whether participant was ‘ever arrested’ (4) 
x Diagnoses based on the DSM-IV (11#, 15#, 18#) 
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x Diagnoses based on DSM5 (13#) 
x P-factor based on DAWBA, the Social and Communication Disorders Checklist (SCDC) (20) 
x 3 subscales (Drive for Thinness, Bulimia, and Body Dissatisfaction) from the Eating Disorder 
Inventory-2 (EDI-2) (23) 
x Specific Psychotic Experiences Questionnaire (32)  
x Neuroticism assessed by Big Five questionnaire (32) 
x Eysenck Personality Inventory Neuroticism Scale–Revised (41) 
x Diagnoses based on ICD-10 codes (41, 42) 
x Development and Well-Being Assessment (DAWBA) (42) 
x Mood and Feelings Questionnaire (43) 
x Family history measured as the number of family members with a history of depression or 
schizophrenia weighted by relatedness (first or second-degree relative) (43) 
Neuropsychological constructs (6) x Behavior Rating Inventory of Executive Function (BRIEF), a 86-item questionnaire. The 
Behavior Regulation Index (which incorporates 3 subscales: inhibit, shift, and emotional 
control) and the Metacognition Index (which incorporates 5 subscales: initiate, working 
memory, plan/organize, organization of materials, and monitor).  The Global Executive 
Composite Index comprised all 8 above subscales (9#) 
x Working memory index from the Wechsler Intelligence Scale for Children–Fourth Edition (15#) 
x Laboratory measures of working memory, response inhibition, executive functioning, 
arousal/attention, temporal, information processing, and processing speed (29#) 
x Working memory spans assessed through number of correctly recalled digits/tapping patterns 
(35#) 
x Processing speed assessed using visual matching task (from the Woodcock Johnson III Test of 
Cognitive Abilities) (35#) 
x Conners’ Continuous Performance Test (35#) 
x Cambridge Neuropsychological Testing Automated Battery (37) 
x Monetary Choice Questionnaire (37) 
x Working memory assessed using digit span backward, spatial span backward, and N-back task 
(38#) 
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Physical health (4) x Body mass index (BMI) (4, 21, 32, 41)  
x Patient-reported hypertension or high blood cholesterol as assessed by a doctor (4)   
x Height (32) 
x Self-rated health (RAND Short-Form Health Survey) (32) 
Socio-economic variables (4) x Six later-life US labor market outcomes: currently working for pay, individual earnings (gross 
individual income), total household wealth (net value of total wealth, excluding second home, 
if applicable), receiving governmental assistance in the form of social security disability 
insurance, receiving unemployment or workers’ compensation, receiving other governmental 
transfers (7) 
x paternal income, maternal education (19#) 
x Socio Economic Status: based on maternal age at birth of the first child, maternal and 
paternal highest education level, and maternal and paternal occupation (32) 
x Socio-economic adversity scale (biological mother’s education, biological father’s education, 
homeownership status, annual household income) (44#) 
Other (9) x Mild traumatic brain injury (2) 
x Age of onset BP (18#) 
x Parental Substance Use Disorder, parental mental disorder (19#) 
x The Structured Interview of Parent Management Skills and Practices Youth-Version (SIPMSP) 
(24) 
x The community disadvantage score was calculated using census-tract level items from the 
1990 and 2000 Decennial census (24) 
x Study participation defined as responding to a questionnaire or attending a clinic for which 
the whole cohort was eligible to participate (31) 
x Bullying and Friendship Interview Schedule (BFIS) (33) 
x 568,281 probes assessed for DNA methylation on the MethylationEPIC BeadChip (34#) 
x Neuromotor functioning: Touwen’s Neurodevelopmental Examination (36)  
x Victimization adversity scale (emotional abuse, physical abuse, sexual abuse, neglect, 
exposure to violence at home, bullying (44#)  
Note: #clinical sample, or enriched sample  
